Focal epilepsy

partial epilepsy: A seizure caused by a localized disorder.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — G40.0, G40.1, G40.2 Hospital discharge: ICD-9 — 345[45] Hospital discharge: ICD-8 — 3453 Cause of death: ICD-10 — G40.0, G40.1, G40.2 Cause of death: ICD-9 — 345[45] Cause of death: ICD-8 — 3453 2 out of 7 registries used, show all original rules.	10112
4. Check minimum number of events None	10112
5. Include endpoints None	10112
6. Filter based on genotype QC (FinnGen only)	9820

Control definitions (FinnGen only)

Control exclude: G6_EPLEPSY

Extra metadata

First used in FinnGen datafreeze: DF3
Parent code in ICD-10: G40

NAME	FE
CONTROL_EXCLUDE	G6_EPLEPSY
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	G40[0-2]
HD_ICD_9	345[45]
HD_ICD_8	3453
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	G40[0-2]
COD_ICD_9	345[45]
COD_ICD_8	3453
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Focal epilepsy based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	93716	43658	49305
Only index persons	78280	37622	40658
Unadjusted period prevalence (%)
Whole population	1.31	1.25	1.38
Only index persons	1.47	1.38	1.55
Median age at first event (years)
Whole population	51.09	50.54	51.41
Only index persons	49.13	48.68	49.54

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	9820	4918	4902
Unadjusted period prevalence (%)	1.99	1.74	2.25
Median age at first event (years)	53.70	48.77	58.65

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
10112: Matched controls
101062

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

AA1BM

NOMESCO Finland

MRI examination of brain with 3 Tesla magnet

10.9

312.1

339

321

R55

ICD-10 Finland

Syncope and collapse

3.0

309.2

1590

5926

N03AX18

ATC

lacosamide; systemic

1239.3

307.7

1202

G40.00

ICD-10 Finland

Benign childhood epilepsy with centrotemporal EEG spikes

4420.2

307.7

434

AAG50

NOMESCO Finland

Stereotactic intracranial radiotherapy

29.2

307.7

279

G40.29

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

+∞

307.7

3749

N03AE01

ATC

clonazepam; systemic

4.3

307.7

1004

2499

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.8

307.7

1597

4732

G40.39

ICD-10 Finland

Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures

4441.9

307.7

436

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

3.5

307.7

1323

4132

7803A

ICD-9 Finland

General symptoms, Convulsions

14.5

307.7

327

232

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

7.7

307.7

2363

3858

C79.30

ICD-10 Finland

Secondary malignant tumor of the cerebrum

13.4

307.7

311

238

G40.2

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures

13497.7

307.7

1203

ZXC95

NOMESCO Finland

Use of surgical navigator

11.1

307.7

373

348

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

4.9

307.7

821

1774

G40.21

ICD-10 Finland

Partial epileptic seizure with cloudiness and automatism

3534.5

307.7

682

N03AX14

ATC

levetiracetam; systemic

261.5

307.7

3997

252

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

+∞

307.7

8503

G40.1

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

+∞

307.7

495

I69.3

ICD-10 Finland

Sequelae of cerebral infarction

5.2

307.7

1595

3523

N03AX09

ATC

lamotrigine; oral

9.8

307.7

1578

1865

G40.20

ICD-10 Finland

Complex partial seizures with only alteration of consciousness

16384.0

307.7

1800

G40.9

ICD-10 Finland

Epilepsy, unspecified

2364.3

307.7

4330

N03AF02

ATC

oxcarbazepine; oral

191.6

307.7

4358

398

G40.10

ICD-10 Finland

Simple partial seizures

14298.2

307.7

1265

I69.1

ICD-10 Finland

Sequelae of intracerebral haemorrhage

17.2

307.7

464

281

N05BA01

ATC

diazepam; systemic, rectal

4.0

307.7

2277

6808

N05BA09

ATC

clobazam; oral

403.8

307.7

885

G41.9

ICD-10 Finland

Status epilepticus, unspecified

128.9

307.7

526

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.7

307.7

2272

9797

AA1DG

NOMESCO Finland

Very extensive MRI examination of brain with high intensity magnet

8.5

307.7

880

1115

XA800

NOMESCO Finland

Neuropsychological investigation

7.9

307.7

1259

1781

G40.11

ICD-10 Finland

Simple partial epileptic seizure that develops into a complex partial seizure

+∞

307.7

433

AA1CM

NOMESCO Finland

Extensive MRI examination of brain with 3 Tesla magnet

11.2

307.7

641

608

183

Kela drug reimbursment

Lamotrigin and topiramate

+∞

307.7

1383

AA1AD

NOMESCO Finland

CT of head and brain

5.1

307.7

5048

16590

AAB10

NOMESCO Finland

Partial excision of intracranial lesion

42.5

307.7

698

176

G41.0

ICD-10 Finland

Grand mal status epilepticus

151.7

307.7

179

N03AF01

ATC

carbamazepine; oral, rectal

21.0

307.7

2558

1605

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

5.2

307.7

1918

4383

C71.20

ICD-10 Finland

Malignant tumor in temporal lobe without histology

101.6

307.7

170

N88

ICPC

Epilepsy

815.4

307.7

755

N03AG01

ATC

valproic acid; systemic, rectal

29.4

307.7

3678

1929

G40.19

ICD-10 Finland

Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures

5704.6

307.7

1048

G40.12

ICD-10 Finland

Simple partial seizures with secondary generalization

16384.0

307.7

1430

I63.9

ICD-10 Finland

Cerebral infarction, unspecified

3.7

307.7

1677

5146

182

Kela drug reimbursment

Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide

16384.0

307.7

3731

R56.8

ICD-10 Finland

Other and unspecified convulsions

43.5

307.7

3893

1434

C71.11

ICD-10 Finland

Malignant tumor of frontal lobe grade II glioma

174.9

307.7

172

G40.89

ICD-10 Finland

Other epilepsy

5076.2

307.7

494

AAB00

NOMESCO Finland

Extirpation of intracranial lesion

17.5

307.7

549

331

N05CD08

ATC

midazolam; nasal, systemic

10.9

307.7

752

740

D43.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, supratentorial

39.0

307.7

405

108

G40.22

ICD-10 Finland

Complex partial epileptic seizure with secondary generalization

+∞

307.7

4218

3454A

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]

+∞

307.7

341

G40.09

ICD-10 Finland

Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset

6435.9

307.7

616

N03AX15

ATC

zonisamide; oral

72.9

307.7

256

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

3.4

307.7

2729

9846

N03AX23

ATC

brivaracetam; systemic

+∞

307.7

354

G40

ICD-10 Finland

Epilepsy

1106.4

307.7

1087

C71.10

ICD-10 Finland

Malignant tumor in frontal lobe without histology

96.4

307.7

254

D32.00

ICD-10 Finland

Benign tumor of the meninges on the outer surface of the cerebrum

10.2

307.7

373

377

N03AX11

ATC

topiramate; oral

9.2

307.7

687

795

G40.6

ICD-10 Finland

Grand mal seizures, unspecified (with or without petit mal)

1833.9

307.7

339

N03AB02

ATC

phenytoin; systemic

64.3

307.7

812

137

XA400

NOMESCO Finland

EEG

24.8

307.7

287

119

L01AX03

ATC

temozolomide; systemic

47.5

307.7

523

116

I69.0

ICD-10 Finland

Sequelae of subarachnoid haemorrhage

13.0

301.8

291

229

O99.3

ICD-10 Finland

Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium

8.7

298.8

384

456

Z2445

NOMESCO Finland

Psychologist

4.4

295.3

778

1865

I61.9

ICD-10 Finland

Intracerebral haemorrhage, unspecified

8.5

294.9

385

466

K90

ICPC

Stroke/cerebrovascular accident

5.6

290.0

568

1059

H02AB02

ATC

dexamethasone; systemic

3.0

288.6

1492

5564

T90.5

ICD-10 Finland

Sequelae of intracranial injury

10.2

284.2

323

326

G41.2

ICD-10 Finland

Complex partial status epilepticus

99.4

283.5

147

N03AX22

ATC

perampanel; oral

2573.9

270.7

261

N07

ICPC

Convulsion/seizure

43.3

265.2

158

78020

ICD-8 Finland

Certain symptoms referable to nervous system and special senses, Convulsions

11.5

262.0

274

245

R41.0

ICD-10 Finland

Disorientation, unspecified

5.1

260.3

574

1188

34599

ICD-8 Finland

Epilepsy, Other and unspecified

+∞

252.1

241

I61.1

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, cortical

14.6

250.9

226

158

AA1BD

NOMESCO Finland

Extensive CT of head and brain

5.7

250.3

476

862

AA5BD

NOMESCO Finland

CT of cerebral ischaemia

5.9

249.0

457

800

C71.2

ICD-10 Finland

Malignant neoplasm: Temporal lobe

107.1

246.9

127

C71.1

ICD-10 Finland

Malignant neoplasm: Frontal lobe

81.0

240.6

128

S06.5

ICD-10 Finland

Traumatic subdural haemorrhage

4.7

239.4

569

1253

9530/0-C70.0

ICD-O-3

Meningioma, NOS, of cerebral meninges

13.8

233.7

217

160

C71.13

ICD-10 Finland

Malignant tumor of frontal lobe grade IV glioma

77.8

229.9

123

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

2.4

228.2

2005

9616

C71.90

ICD-10 Finland

Malignant tumor in unspecified localization in the brain without histology

30.8

227.9

149

H53.4

ICD-10 Finland

Visual field defects

6.0

227.8

415

721

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

2.8

227.3

1287

5005

G40.4

ICD-10 Finland

Other generalized epilepsy and epileptic syndromes

2115.0

224.6

217

3459X

ICD-9 Finland

Epilepsy, unspecified

+∞

220.6

211

C71.23

ICD-10 Finland

Malignant tumor of temporal lobe grade IV glioma

70.2

217.2

118

34532

ICD-8 Finland

Epilepsy, Partialis (focalis) generalisata

+∞

216.4

207

R4150

NOMESCO Finland

Neuropsychological rehabilitation

11.6

213.0

221

195

3451A

ICD-9 Finland

Epilepsy, Generalised convulsive epilepsy

+∞

211.1

202

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.0

211.0

3418

20669

R47.0

ICD-10 Finland

Dysphasia and aphasia

9.5

208.5

248

266

3454B

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[TEMPORAALIEPILEPTINEN POISSAOLOKOHTAUS]

+∞

208.0

199

G40.3

ICD-10 Finland

Generalized idiopathic epilepsy and epileptic syndromes

+∞

205.9

197

I63.3

ICD-10 Finland

Cerebral infarction due to thrombosis of cerebral arteries

4.0

204.8

612

1604

TAB00

NOMESCO Finland

Lumbar puncture

3.7

202.2

680

1935

YX8VG

NOMESCO Finland

Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy

23.9

201.7

144

PA2BD

NOMESCO Finland

Extensive CT angiography of brain

6.7

201.6

326

502

J18.9

ICD-10 Finland

Pneumonia, unspecified

2.0

195.1

2823

16326

AA1DM

NOMESCO Finland

Very extensive MRI examination of brain with 3 Tesla magnet

10.6

193.6

213

205

34530

ICD-8 Finland

Epilepsy, Psychomotorica

+∞

193.3

185

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

6.3

191.6

327

532

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

5.7

191.6

361

647

N18

ICPC

Paralysis/weakness

5.6

190.2

370

683

G40.30

ICD-10 Finland

Benign myoclonic eplilepsy in infancy

+∞

182.8

175

I61.0

ICD-10 Finland

Intracerebral haemorrhage in hemisphere, subcortical

6.4

181.2

304

486

YX8BD

NOMESCO Finland

Stereotactic extensive CT examination for dose design of radiotherapy

15.4

181.1

158

104

A28

ICPC

Limited function/disability NOS

2.2

180.0

1903

9756

130

Kela drug reimbursment

Malignant tumour

2.7

178.3

1099

4437

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

3.0

177.7

845

2973

N05AX08

ATC

risperidone; systemic

2.7

177.0

1069

4271

S06.3

ICD-10 Finland

Focal brain injury

6.9

173.1

271

403

N03AG04

ATC

vigabatrin; oral

+∞

169.2

162

G40.0

ICD-10 Finland

Localization-related (focal)(partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset

1734.2

169.1

164

ZXC40

NOMESCO Finland

Use of ultrasound

10.2

168.6

190

189

G45.9

ICD-10 Finland

Transient cerebral ischaemic attack, unspecified

2.7

167.2

977

3834

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

8.6

166.2

214

254

AAG00

NOMESCO Finland

Stereotactic intracranial biopsy

31.8

165.2

107

D43.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified

21.7

159.0

118

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

9.2

157.5

191

210

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.7

157.4

923

3625

D32.02

ICD-10 Finland

Benign tumor of the meninges at the base of the brain

8.6

155.5

200

237

AAC00

NOMESCO Finland

Ligature of intracranial aneurysm

7.7

154.0

216

284

WX892

NOMESCO Finland

Monitored bed care

2.6

150.6

946

3842

R4120

NOMESCO Finland

Occupational therapy

2.8

150.2

826

3136

R1230

NOMESCO Finland

Neuropsychological evaluation of need and possibilities to rehabilitation

6.9

149.8

234

347

I60.1

ICD-10 Finland

Subarachnoid haemorrhage from middle cerebral artery

12.3

148.0

147

121

S06.0

ICD-10 Finland

Concussion

2.3

147.6

1294

6111

N06AB04

ATC

citalopram; systemic

1.9

143.6

2150

12391

9440/3-C71.9

ICD-O-3

Glioblastoma, NOS, of brain, NOS

44.5

141.8

F02.89*G40.9

ICD-10 Finland

Dementia in epilepsy

+∞

140.9

135

R51.80

ICD-10 Finland

Headache

2.0

137.4

1684

9040

D32.01

ICD-10 Finland

Benign tumor of meninges on interhemispheric surface

13.0

137.3

132

103

PA7AD

NOMESCO Finland

CT angiography of head and neck vasculature

3.5

136.2

482

1413

34510

ICD-8 Finland

Epilepsy, """"Grand mal""""

+∞

135.7

130

N03AF04

ATC

eslicarbazepine; oral

+∞

135.7

130

R53

ICD-10 Finland

Malaise and fatigue

1.8

135.3

2515

15490

XF400

NOMESCO Finland

ECG with 12 standard connections

2.0

135.1

1752

9591

T36

ICD-10 Finland

Poisoning by systemic antibiotics

3.2

134.1

558

1810

AA1AG

NOMESCO Finland

Short MRI examination of brain with median intensity magnet

5.4

133.5

267

505

AAK00

NOMESCO Finland

Cranioplasty

37.5

132.7

C71.30

ICD-10 Finland

Malignant tumor in parietal lobe without histology

48.5

132.3

C71.99

ICD-10 Finland

Malignant tumor in unspecified localization in the brain other or unspecified histology

37.1

130.6

D43.2

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, unspecified

24.0

130.5

N05AH04

ATC

quetiapine; oral

1.9

129.7

1869

10594

181

Kela drug reimbursment

Retigabine and vigabatrin

+∞

129.4

124

PA6BD

NOMESCO Finland

Extensive CT of neck arteries

3.3

129.1

506

1582

F05.9

ICD-10 Finland

Delirium, unspecified

4.5

128.7

324

744

W19

ICD-10 Finland

Unspecified fall

2.3

128.5

1142

5406

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

126.4

1386

7124

C71.12

ICD-10 Finland

Malignant tumor of frontal lobe grade III glioma

215.9

124.0

128

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

123.3

4441

32608

L28

ICPC

Limited function/disability (L)

1.9

120.8

1779

10133

WX882

NOMESCO Finland

High dependency care

3.4

120.6

450

1364

AAF00

NOMESCO Finland

Ventriculostomy

9.6

118.0

139

147

ZX050

NOMESCO Finland

Stereotactic radiotherapy

7.4

117.7

171

234

I60.9

ICD-10 Finland

Subarachnoid haemorrhage, unspecified

5.6

114.5

220

401

N05BA04

ATC

oxazepam; oral

1.7

114.1

2540

16361

A06AD11

ATC

lactulose; oral

2.0

114.0

1538

8490

ADB00

NOMESCO Finland

Implantation of vagus nerve stimulating device

1120.6

113.8

111

G41.8

ICD-10 Finland

Other status epilepticus

44.9

113.2

K91

ICPC

Cerebrovascular disease

5.4

113.0

227

431

SPAT1217

SPAT

Assessment of need for services (elderly/care support)

2.4

112.7

807

3471

D32.9

ICD-10 Finland

Benign neoplasm: Meninges, unspecified

11.7

112.5

115

R42

ICD-10 Finland

Dizziness and giddiness

1.8

112.5

2245

14011

SPAT1226

SPAT

Implementation of occupational therapy rehabilitation plan

3.8

109.8

344

928

SPAT1229

SPAT

Assessment of need for aid

2.4

109.8

848

3771

N05AH03

ATC

olanzapine; systemic

2.5

109.4

710

2916

R40.2

ICD-10 Finland

Coma, unspecified

7.0

109.2

167

242

F70.0

ICD-10 Finland

Mild mental retardation, With the statement of no, or minimal, impairment of behaviour

11.7

108.3

111

Z2446

NOMESCO Finland

Social worker

2.4

106.9

803

3526

Z51.5

ICD-10 Finland

Palliative care

2.3

106.4

846

3808

G91.0

ICD-10 Finland

Communicating hydrocephalus

9.7

105.6

123

128

B01AC30

ATC

platelet aggregation inhibitors excl. heparin - combinations

2.5

105.6

681

2787

TPH04

NOMESCO Finland

Cathetrisation of vein

1.7

105.0

2189

13794

Q28.2

ICD-10 Finland

Arteriovenous malformation of cerebral vessels

16.0

104.3

N28

ICPC

Limited function/disability (N)

4.5

103.6

253

567

WX730

NOMESCO Finland

Conventional respirator

4.7

103.1

244

533

N74

ICPC

Malignant neoplasm nervous system

34.4

102.6

SPAT1216

SPAT

Assessment of functional ability

1.9

102.0

1541

8805

R56.0

ICD-10 Finland

Febrile convulsions

9.4

101.5

121

130

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

2.4

100.9

741

3219

S01.0

ICD-10 Finland

Open wound of scalp

2.2

100.0

876

4104

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

6.4

99.4

166

264

WX872

NOMESCO Finland

Intensive care

2.6

98.2

585

2302

S06.2

ICD-10 Finland

Diffuse brain injury

5.9

97.4

177

306

PA2CC

NOMESCO Finland

Cerebral very extensive angiography with X-ray

7.2

97.4

145

204

R4130

NOMESCO Finland

Speech therapy

3.5

95.4

340

1000

PA2BC

NOMESCO Finland

Cerebral extensive angiography with X-ray

6.0

95.3

168

282

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

94.5

1500

8688

C71.21

ICD-10 Finland

Malignant tumor of temporal lobe grade II glioma

197.8

94.5

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

3.1

93.3

401

1323

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.0

93.3

1068

5542

N29

ICPC

Neurological sympt/complt other

3.9

92.3

277

725

ZXE20

NOMESCO Finland

More than three and less than five hours

1.9

91.9

1360

7700

N02AA05

ATC

oxycodone; systemic

1.8

91.2

1671

10100

AAF05

NOMESCO Finland

Ventriculoperitoneal shunt

5.3

90.9

186

359

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

2.3

90.9

765

3521

I63.4

ICD-10 Finland

Cerebral infarction due to embolism of cerebral arteries

3.2

90.7

374

1204

C71.33

ICD-10 Finland

Malignant tumor of parietal lobe grade IV glioma

52.2

90.5

G80.2

ICD-10 Finland

Spastic hemiplegic cerebral palsy

25.3

90.1

TKC20

NOMESCO Finland

Catheterisation of bladder

2.3

90.1

751

3442

34539

ICD-8 Finland

Epilepsy, Partialis (focalis) NUD

+∞

88.6

A03FA01

ATC

metoclopramide; systemic, rectal

1.7

88.6

2014

12920

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.8

88.5

1557

9291

C71.3

ICD-10 Finland

Malignant neoplasm: Parietal lobe

51.2

88.4

AEA50

NOMESCO Finland

Adjustment of implanted neurostimulator

10.8

87.9

NA1AD

NOMESCO Finland

Cervical spine CT examination

2.6

87.4

512

1996

C71.00

ICD-10 Finland

Malignant tumor of the cerebrum except lobes and ventricles without histology

29.1

87.0

WYA30

NOMESCO Finland

Treatment of a patient needing special arrangements

2.1

87.0

863

4240

A49.9

ICD-10 Finland

Bacterial infection, unspecified

1.9

85.2

1115

6052

XCK00

NOMESCO Finland

Perimetry

2.3

85.1

666

2970

AAF20

NOMESCO Finland

Revision of shunt of ventricle of brain

9.4

84.1

100

107

AA5PD

NOMESCO Finland

CT examination of brain pefusion

6.0

83.9

149

252

A04AA02

ATC

granisetron; systemic, transdermal

2.4

83.7

635

2793

SPAT1137

SPAT

Taking care of patient’s/customer’s hygiene

2.4

83.5

606

2614

SPAT1234

SPAT

Support of social functional capacity

2.5

83.4

571

2398

N19

ICPC

Speech disorder

4.1

83.1

231

572

N05AA02

ATC

levomepromazine; systemic

2.8

82.9

445

1659

I67.1

ICD-10 Finland

Cerebral aneurysm, nonruptured

4.0

82.5

239

610

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.8

82.1

1285

7386

N76

ICPC

Neoplasm nervous system unspecified

26.8

81.7

ZXD05

NOMESCO Finland

Urgent procedure

1.6

80.4

2898

20731

A86

ICD-10 Finland

Unspecified viral encephalitis

8.4

79.6

103

123

AA5DR

NOMESCO Finland

Brain metabolism PET with CT

17.9

79.2

3454X

ICD-9 Finland

Epilepsy, Partial epilepsy, with impairment of consciousness[ALII DISTURBATIONES CONSCIENTAE EPILEPTICI]

+∞

78.2

N05CF01

ATC

zopiclone; oral

1.5

78.2

2922

21045

F79.0

ICD-10 Finland

Unspecified mental retardation, with the statement of no, or minimal, impairment of behaviour

12.1

77.9

H47.2

ICD-10 Finland

Optic atrophy

8.7

77.8

113

R1260

NOMESCO Finland

Evaluation of communicative skills

4.0

77.0

223

569

PA6AD

NOMESCO Finland

CT of neck arteries

3.1

76.8

338

1130

C03CA01

ATC

furosemide; systemic

1.6

76.4

2729

19442

G41.1

ICD-10 Finland

Petit mal status epilepticus

45.2

75.9

C71.22

ICD-10 Finland

Malignant tumor of temporal lobe grade III glioma

196.4

75.2

SPAT1254

SPAT

Administration of medicine

1.7

75.2

1488

9150

XX3DW

NOMESCO Finland

Time consuming IT work

1.9

74.8

1014

5558

PA6DE

NOMESCO Finland

Neck artery ultrasound examination with Doppler method

2.5

74.6

508

2127

G81.9

ICD-10 Finland

Hemiplegia, unspecified

5.0

74.2

161

327

PA2AD

NOMESCO Finland

CT angiography of brain

6.0

74.1

132

224

G40.36

ICD-10 Finland

Juvenile myoclonic epilepsy [impulsive petit mal]

+∞

73.0

D32.0

ICD-10 Finland

Benign neoplasm: Cerebral meninges

9.5

72.9

N05CD07

ATC

temazepam; oral

1.9

72.3

1078

6088

X59

ICD-10 Finland

Exposure to unspecified factor

1.6

72.2

1821

11926

N06AX11

ATC

mirtazapine; oral

1.5

72.1

3052

22491

WF002

NOMESCO Finland

Radical radiotherapy

2.3

71.2

559

2493

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

7.5

70.6

101

136

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.7

70.4

1661

10688

M03BX01

ATC

baclofen; systemic

3.7

69.9

229

637

Q28.3

ICD-10 Finland

Other malformations of cerebral vessels

9.4

69.7

Z3231

NOMESCO Finland

Registered nurse

1.5

69.4

2603

18671

G04.9

ICD-10 Finland

Encephalitis, myelitis and encephalomyelitis, unspecified

10.9

69.3

G40.51

ICD-10 Finland

Epileptic seizures related to alcohol

682.7

69.1

G40.7

ICD-10 Finland

Petit mal, unspecified, without grand mal seizures

234.8

68.3

P20

ICPC

Memory disturbance

1.8

66.3

1197

7153

SPAT1301

SPAT

No procedures

1.5

66.2

2891

21363

N05BA06

ATC

lorazepam; systemic, sublingual

2.3

65.7

512

2274

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

3.1

65.4

279

916

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

3.7

65.3

212

586

F71.0

ICD-10 Finland

Moderate mental retardation, with the statement of no, or minimal, impairment of behaviour

27.6

64.7

AAJ20

NOMESCO Finland

Excision of epileptic focus

+∞

64.6

N99

ICPC

Neurological disease other

4.3

64.6

169

400

9530/0-C70.9

ICD-O-3

Meningioma, NOS, of meninges, NOS

12.7

63.9

R11

ICD-10 Finland

Nausea and vomiting

1.9

63.8

862

4709

P85

ICPC

Mental retardation

10.7

63.6

D33.00

ICD-10 Finland

Medial pilosytic astrocytoma of the cerebrum

16.0

63.1

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.7

63.1

1380

8685

R46.8

ICD-10 Finland

Other symptoms and signs involving appearance and behaviour

17.7

62.7

PA7BD

NOMESCO Finland

CT angiography of neck and brain

3.7

62.6

202

556

N06AB10

ATC

escitalopram; oral

1.6

62.6

1832

12390

PA7CD

NOMESCO Finland

CT angiography of neck and brain, extensive

4.5

62.4

151

336

R1250

NOMESCO Finland

Evaluation of functional capability

3.1

61.9

259

841

34533

ICD-8 Finland

Epilepsy, Partialis (focalis) alia

+∞

61.5

N05AD01

ATC

haloperidol; systemic

2.7

61.2

333

1249

F29

ICD-10 Finland

Unspecified nonorganic psychosis

2.5

61.1

381

1529

Z01.8

ICD-10 Finland

Other specified special examinations

1.5

61.1

2044

14240

AAD05

NOMESCO Finland

Evacuation of acute subdural haematoma

7.8

61.1

108

ZXE30

NOMESCO Finland

More than five and less than seven hours

2.3

61.0

495

2236

R50.9

ICD-10 Finland

Fever, unspecified

1.6

60.9

1452

9337

4380A

ICD-9 Finland

Late effects of cerebrovascular disease[SEQUELAE MORBI CEREBROVASCULARIS]

8.0

60.8

103

G40.80

ICD-10 Finland

Epilepsy with continuous EEG spike-waves during slow wave sleep

+∞

60.5

R41.3

ICD-10 Finland

Other amnesia

2.8

60.1

312

1142

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.9

60.0

780

4205

3453A

ICD-9 Finland

Epilepsy, Grand mal status

591.4

59.8

F80.1

ICD-10 Finland

Expressive language disorder

4.4

59.7

151

348

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.7

58.8

1206

7453

S06.6

ICD-10 Finland

Traumatic subarachnoid haemorrhage

4.7

57.8

134

288

AAA10

NOMESCO Finland

Biopsy through craniotomy

21.6

57.7

G40.59

ICD-10 Finland

Other special epileptic syndromes

571.1

57.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.9

57.5

849

4765

Z3226

NOMESCO Finland

Physiotherapist

1.6

57.4

1669

11246

N03AX25

ATC

cenobamate; oral

+∞

57.3

3455A

ICD-9 Finland

Epilepsy, Partial epilepsy, without mention of impairment of consciousness

+∞

57.3

I69.2

ICD-10 Finland

Sequelae of other nontraumatic intracranial haemorrhage

12.2

57.2

N03AX12

ATC

[U] gabapentin; oral

1.6

57.2

1423

9238

S06.4

ICD-10 Finland

Epidural haemorrhage

13.7

56.1

G91.1

ICD-10 Finland

Obstructive hydrocephalus

7.7

55.9

102

N03AA02

ATC

phenobarbital; systemic

21.1

55.8

RS222, ,

NOMESCO Finland

3.9

55.6

166

433

AAB30

NOMESCO Finland

Evacuation of spontaneous intracranial haematoma

14.9

55.3

I63.0

ICD-10 Finland

Cerebral infarction due to thrombosis of precerebral arteries

3.8

54.9

172

464

H02AB09

ATC

hydrocortisone; systemic

2.8

54.9

284

1038

AAA27

NOMESCO Finland

Insertion of intracerebral pressure monitoring device

17.4

54.9

N02BE01

ATC

paracetamol; systemic, rectal

1.5

54.8

8337

76262

ZXM40

NOMESCO Finland

Use of fluorescent substance

16.5

54.7

AAD15

NOMESCO Finland

Evacuation of traumatic intracerebral haematoma

20.1

54.7

N03AG06

ATC

tiagabine; oral

540.8

54.6

D43.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Brain, infratentorial

12.7

54.5

B01AC04

ATC

clopidogrel; oral

1.6

54.5

1428

9378

2152

FHL

Extraction, big brain

15.1

54.4

2161

FHL

Neck ligation, big brain

9.3

54.4

G45.1

ICD-10 Finland

Carotid artery syndrome (hemispheric)

2.5

54.4

358

1474

G80.1

ICD-10 Finland

Spastic diplegic cerebral palsy

16.7

53.9

D32.03

ICD-10 Finland

Benign meningioma in ventricles

16.7

53.9

D32.04

ICD-10 Finland

Secondary or multiple benign tumor of the meninges above the exam

23.0

53.7

4300A

ICD-9 Finland

Subarachnoid haemorrhage[HAEMORRHAGIA SUBARACHNOID. POST ANEURYSMA SACCULARE]

8.5

53.5

AA5FG

NOMESCO Finland

Functional MRI examination of brain with high intensity magnet

272.4

53.2

F83

ICD-10 Finland

Mixed specific developmental disorders

5.0

53.0

114

230

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

53.0

2323

17040

C71.19

ICD-10 Finland

Malignant tumor of frontal lobe other or unspecified histology

75.5

53.0

C71.29

ICD-10 Finland

Malignant tumor in temporal lobe other or unspecified histology

84.8

52.9

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

2.0

52.8

609

3147

R90.8

ICD-10 Finland

Other abnormal findings on diagnostic imaging of central nervous system

4.2

52.6

141

340

SPAT1231

SPAT

Assessment of adjustments needed in living environment

3.2

52.2

212

676

B01AA03

ATC

warfarin; systemic

1.5

51.6

1702

11768

A04

ICPC

Weakness/tiredness general

1.6

51.0

1354

8908

ZXE10

NOMESCO Finland

More than one and less than three hours

1.4

50.7

3133

24442

G80.9

ICD-10 Finland

Cerebral palsy, unspecified

21.2

50.6

AAD10

NOMESCO Finland

Evacuation of chronic subdural haematoma

3.9

50.2

151

396

G40.8

ICD-10 Finland

Other epilepsy

+∞

50.0

A02BC02

ATC

pantoprazole; systemic

1.4

49.7

6030

52396

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.0

49.5

225

766

OAB43, ,

SPAT

0.6

49.4

1203

17956

R90.0

ICD-10 Finland

Intracranial space-occupying lesion

14.1

49.3

R4110

NOMESCO Finland

Physiotherapy

1.4

49.2

2406

17979

34598

ICD-8 Finland

Epilepsy, Alia definita

+∞

49.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

2.9

48.9

231

804

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.0

48.7

584

3057

SPAT1245

SPAT

Provision of support and information to patient’s family members

2.2

48.3

418

1938

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.2

48.2

437

2064

N03AD01

ATC

ethosuximide; oral

+∞

47.9

G72.8

ICD-10 Finland

Other specified myopathies

3.4

47.9

176

528

I60.0

ICD-10 Finland

Subarachnoid haemorrhage from carotid siphon and bifurcation

8.0

47.7

I69.8

ICD-10 Finland

Sequelae of other and unspecified cerebrovascular diseases

6.4

47.5

122

AAJ99

NOMESCO Finland

Other operation for epilepsy

+∞

46.9

G40.50

ICD-10 Finland

Epilepsia partialis continua [Kozhevnikof]

+∞

46.9

F70.9

ICD-10 Finland

Mild mental retardation, Without mention of impairment of behaviour

13.4

46.7

F10.20

ICD-10 Finland

Alcohol dependence currently independent

3.0

46.4

209

708

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.4

46.3

2683

20631

ZXY02

NOMESCO Finland

Neuropsychologist

5.5

46.2

163

N05AF03

ATC

chlorprothixene; systemic

2.7

46.2

250

936

I63.8

ICD-10 Finland

Other cerebral infarction

4.2

46.0

122

292

R25.2

ICD-10 Finland

Cramp and spasm

2.7

45.9

247

922

9440/3-C71.2

ICD-O-3

Glioblastoma, NOS, of temporal lobe

85.5

45.8

R25.1

ICD-10 Finland

Tremor, unspecified

2.5

45.8

306

1269

XX1XW

NOMESCO Finland

Extensive written report from radiologist

2.8

45.4

229

826

F10.25

ICD-10 Finland

Alcohol dependence continuous use

3.2

45.3

183

582

G81.1

ICD-10 Finland

Spastic hemiplegia

12.2

45.2

SPAT1240

SPAT

Therapeutic discussion

1.7

45.2

927

5708

F44.5

ICD-10 Finland

Dissociative convulsions

83.8

44.8

34519

ICD-8 Finland

Epilepsy, Generalisata convulsiva NUD

+∞

44.8

ZSA00

NOMESCO Finland

Procedure related to previous procedure classified in chapter A

7.3

44.8

N03AX16

ATC

[U] pregabalin

1.5

44.3

1936

14126

G91.9

ICD-10 Finland

Hydrocephalus, unspecified

6.4

44.2

115

G06.0

ICD-10 Finland

Intracranial abscess and granuloma

15.0

44.2

F79.9

ICD-10 Finland

Unspecified mental retardation, without mention of impairment of behaviour

15.0

44.2

Z50.9

ICD-10 Finland

Care involving use of rehabilitation procedure, unspecified

2.2

44.0

384

1786

1541, ,

Kela drug reimbursment

+∞

43.8

3069, ,

Kela drug reimbursment

+∞

43.8

WF003

NOMESCO Finland

Adjuvant radiotherapy

2.4

43.7

314

1346

F07.9

ICD-10 Finland

Unspecified organic personality and behavioural disorder due to brain disease, damage and dysfunction

13.8

43.3

N05AX12

ATC

aripiprazole; systemic

2.2

43.0

368

1698

I61.8

ICD-10 Finland

Other intracerebral haemorrhage

8.5

42.9

WF049

NOMESCO Finland

Radiotherapy of metastasis

2.3

42.8

324

1420

SPAT1220

SPAT

Assessment of need for rehabilitation and/or rehabilitation plan

1.9

42.8

567

3068

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

42.8

1708

12237

N06AX16

ATC

venlafaxine; oral

1.6

42.5

1166

7708

R47.8

ICD-10 Finland

Other and unspecified speech disturbances

4.1

42.4

115

280

9400/3-C71.9

ICD-O-3

Astrocytoma, NOS, of brain, NOS

419.2

42.2

PA2AC

NOMESCO Finland

Cerebral angiography with X-ray

6.5

42.0

105

F70.1

ICD-10 Finland

Mild mental retardation, Significant impairment of behaviour requiring attention or treatment

10.5

41.9

C71.31

ICD-10 Finland

Malignant tumor of the parietal lobe grand II glioma

147.2

41.8

Z02.4

ICD-10 Finland

Examination for driving licence

0.6

41.7

1196

17318

G40.35

ICD-10 Finland

Juvenile absence epilepsy

+∞

41.7

A29

ICPC

General symptom/complaint other

1.6

41.5

1085

7093

N05AB03

ATC

perphenazine; systemic, rectal

2.3

41.4

317

1397

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

3.9

41.2

120

308

AWB00

NOMESCO Finland

Reoperation for superficial infection in surgery of the nervous system

9.6

41.2

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

3.2

41.0

164

519

S22.3

ICD-10 Finland

Fracture of rib

1.8

40.8

622

3516

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

2.1

40.6

405

1984

I67.6

ICD-10 Finland

Nonpyogenic thrombosis of intracranial venous system

9.4

40.6

SPAT1215

SPAT

Assessment of need for medical rehabilitation

2.1

40.6

387

1864

B01AC07

ATC

dipyridamole; systemic

2.1

40.4

406

1994

I63.1

ICD-10 Finland

Cerebral infarction due to embolism of precerebral arteries

3.5

40.3

138

396

ZXM00

NOMESCO Finland

Intraoperative use of ultrasonographic imaging

4.0

40.1

112

279

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.5

40.1

1195

8045

N05AH02

ATC

clozapine; systemic

2.9

40.0

185

637

F03

ICD-10 Finland

Unspecified dementia

2.1

39.8

370

1764

I60.8

ICD-10 Finland

Other subarachnoid haemorrhage

10.0

39.7

A04AA01

ATC

ondansetron; systemic, rectal

1.8

39.6

669

3898

F05.8

ICD-10 Finland

Other delirium

4.5

39.5

215

ZXD35

NOMESCO Finland

Usual procedure

2.3

39.4

311

1388

G93.0

ICD-10 Finland

Cerebral cysts

6.2

39.3

109

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

2.9

39.3

189

665

9400/3-C71.1

ICD-O-3

Astrocytoma, NOS, of frontal lobe

388.9

39.1

F10.41

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol with seizures

8.5

39.0

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.4

39.0

2349

18085

GBB00

NOMESCO Finland

Tracheostomy

3.6

38.9

127

353

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

2.1

38.9

389

1907

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

3.0

38.8

171

573

H53.2

ICD-10 Finland

Diplopia

2.3

38.6

297

1311

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

4.0

38.6

109

274

ZY010

NOMESCO Finland

Hospital outpatient

1.9

38.5

478

2531

F06.9

ICD-10 Finland

Unspecified mental disorder due to brain damage and dysfunction and to physical disease

7.3

38.5

S42.2

ICD-10 Finland

Fracture of upper end of humerus

2.0

38.2

410

2064

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

38.1

954

6165

SPAT1292

SPAT

Other function in accordance with SHToL (Finnish classification of nursing interventions)

1.7

37.8

748

4553

WYA20

NOMESCO Finland

Home visit

2.9

37.8

182

641

T85.0

ICD-10 Finland

Mechanical complication of ventricular intracranial (communicating) shunt

10.3

37.7

3450A

ICD-9 Finland

Epilepsy, Generalised nonconvulsive epilepsy

+∞

37.5

34500

ICD-8 Finland

Epilepsy, """"Petit mal""""

+∞

37.5

G83.8

ICD-10 Finland

Other specified paralytic syndromes

14.2

37.3

F20.9

ICD-10 Finland

Schizophrenia, unspecified

2.7

37.2

198

735

I95.1

ICD-10 Finland

Orthostatic hypotension

2.1

37.1

343

1632

E87.6

ICD-10 Finland

Hypokalaemia

2.3

37.0

297

1335

TPH07

NOMESCO Finland

Cathetrisation of artery

1.6

37.0

957

6231

AA7AA

NOMESCO Finland

Liquor cerebri shunt X-ray examinatin without contrast

6.6

36.9

F06.8

ICD-10 Finland

Other specified mental disorders due to brain damage and dysfunction and to physical disease

12.4

36.6

N06AB06

ATC

sertraline; oral

1.6

36.6

942

6126

AAJ15

NOMESCO Finland

Hippocampectomy

+∞

36.5

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.4

36.4

1601

11645

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

3.4

36.4

134

403

SPAT1053

SPAT

Memory test

1.5

36.2

1141

7767

SPAT1252

SPAT

Overall medication plan or its review

1.8

36.0

568

3244

N30.0

ICD-10 Finland

Acute cystitis

1.5

36.0

1295

9061

OAA67, ,

SPAT

0.5

35.9

451

8055

I62.0

ICD-10 Finland

Nontraumatic subdural haemorrhage

4.3

35.9

215

WZC00

NOMESCO Finland

Treatment plan or consultation

1.3

35.8

3135

25505

9440/3-C71.1

ICD-O-3

Glioblastoma, NOS, of frontal lobe

47.9

35.6

113

Kela drug reimbursment

Anxiety disorders associated with mental retardation

9.2

35.6

Y0209

ICD-8 Finland

Examination of the nervous system and sensory organs, Nervous system

4.7

35.6

176

N04AA02

ATC

biperiden; systemic

2.8

35.3

177

637

AAC40

NOMESCO Finland

Extirpation of intracranial arterio-venous malformation

58.8

35.1

F10.06

ICD-10 Finland

Alcohol-related acute intoxication with seizures

12.6

34.9

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

2.1

34.8

342

1666

AEA00

NOMESCO Finland

Replacement of impulse generator of stimulation device in the nervous system

5.3

34.8

130

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.9

34.7

460

2488

G40.33

ICD-10 Finland

Juvenile absence epilepsy

+∞

34.4

H03AA01

ATC

levothyroxine sodium; systemic

1.4

34.3

1812

13608

Z75.5

ICD-10 Finland

Holiday relief care

4.0

34.3

240

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

34.1

622

3702

9450/3-C71.1

ICD-O-3

Oligodendroglioma, NOS, of frontal lobe

175.5

33.7

Q04.8

ICD-10 Finland

Other specified congenital malformations of brain

45.7

33.7

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.5

33.6

1125

7747

P72

ICPC

Schizophrenia

2.7

33.3

179

668

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

2.6

33.1

194

757

S02.11

ICD-10 Finland

Fracture of base of skull, open

6.6

33.1

Y86

ICD-10 Finland

Sequelae of other accidents

5.8

33.1

104

C71.32

ICD-10 Finland

Malignant tumor of parietal lobe grade III glioma

328.1

32.9

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

3.0

32.9

142

471

-, ,

ICD-10 Finland

2.5

32.8

212

866

F10.24

ICD-10 Finland

Alcohol depence active use

2.9

32.8

151

519

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.6

32.8

738

4641

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

1.9

32.8

459

2526

F10.49

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without information about seizures

4.7

32.8

160

S00.0

ICD-10 Finland

Superficial injury of scalp

2.4

32.7

224

940

A41.9

ICD-10 Finland

Sepsis, unspecified

2.1

32.7

324

1584

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.8

32.5

473

2634

WX704

NOMESCO Finland

Intubation

1.7

32.3

671

4133

SPAT1224

SPAT

Implementation of speech therapy rehabilitation plan

2.9

32.3

157

556

AAA35

NOMESCO Finland

Insertion of subdural electrodes

+∞

32.3

WX110

NOMESCO Finland

Infiltration anesthesia

1.3

32.2

6383

57559

I61

ICD-10 Finland

Intracerebral haemorrhage

10.6

32.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

1.3

31.9

2370

18762

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

3.7

31.9

100

271

C79.39

ICD-10 Finland

Secondary malignant tumor of the meninges, ventricle or other part of the brain

8.7

31.8

Q85.1

ICD-10 Finland

Tuberous sclerosis

72.4

31.8

G45.0

ICD-10 Finland

Vertebro-basilar artery syndrome

2.3

31.8

235

1020

N80

ICPC

Head injury other

2.5

31.8

201

813

U04

ICPC

Incontinence urine

1.9

31.3

431

2359

C08CA01

ATC

amlodipine; oral

1.3

31.3

3060

25173

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

3.6

31.2

103

289

N05CD02

ATC

nitrazepam; oral

2.8

31.2

153

545

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

1.6

31.0

812

5293

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

2.0

30.9

324

1617

43090

ICD-8 Finland

Subarachnoid haemorrhage, Postaneurysma sacculare, hypertonia non indicata

10.0

30.9

AWC00

NOMESCO Finland

Reoperation of nervous system because of deep wound infection in the nervous system

33.4

30.8

7819X

ICD-9 Finland

Symptoms involving nervous and musculoskeletal systems, Other symptoms involving nervous and musculoskeletal systems[SYMPTOMATA ALIA SYSTEMATIS NERVORUM ET MUSCULOSCEL]

3.8

30.7

246

AAF25

NOMESCO Finland

Removal of shunt of ventricle of brain

8.1

30.7

N07BB01

ATC

disulfiram; oral

2.0

30.6

356

1843

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.7

30.6

575

3450

PA3AC

NOMESCO Finland

Carotis angiography with X-ray

5.7

30.6

V700A

ICD-9 Finland

General medical examination, Routine general medical examination at a health care facility

2.4

30.5

221

951

P29

ICPC

Psychological sympt/compl other

1.7

30.5

585

3528

P99

ICPC

Psychological disorders other

2.2

30.4

253

1156

RS221, ,

NOMESCO Finland

2.8

30.3

152

548

G40.52

ICD-10 Finland

Epileptic seizures related to drugs

+∞

30.2

G40.01

ICD-10 Finland

Pediatric epilepsy with occipital EEG paroxysms

+∞

30.2

F06.32

ICD-10 Finland

Organic depression

7.7

30.1

G45.4

ICD-10 Finland

Transient global amnesia

2.4

30.1

199

823

B01AB05

ATC

enoxaparin; parenteral

1.3

30.0

2511

20191

R40.0

ICD-10 Finland

Somnolence

5.6

29.9

100

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

2.3

29.8

226

993

I63.5

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries

2.9

29.4

139

485

Z50.5

ICD-10 Finland

Speech therapy

2.7

29.4

158

591

X58

ICD-10 Finland

Exposure to other specified factors

1.4

29.0

1185

8477

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.5

28.9

1079

7585

RL140, ,

NOMESCO Finland

6.7

28.8

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

1.8

28.7

446

2533

C71.01

ICD-10 Finland

Malignant tumor of cerebellum except lobes and ventricles grade II glioma

150.4

28.6

S18

ICPC

Laceration/cut

1.3

28.6

3815

32561

R5110, ,

SPAT

1.7

28.6

505

2977

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

2.6

28.6

169

663

AA9CW, ,

NOMESCO Finland

9.0

28.5

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.9

28.5

348

1832

I63.2

ICD-10 Finland

Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries

3.5

28.5

278

F01.9

ICD-10 Finland

Vascular dementia, unspecified

2.9

28.3

135

474

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.7

28.2

572

3502

R47.1

ICD-10 Finland

Dysarthria and anarthria

3.4

28.0

291

W00

ICD-10 Finland

Fall on same level involving ice and snow

1.5

28.0

890

6055

AAF15

NOMESCO Finland

Ventriculoatrial shunt

6.8

27.9

JN4AD

NOMESCO Finland

Body CT examination

1.5

27.8

792

5262

ZYC01

NOMESCO Finland

Remote contact by phone

1.7

27.6

492

2907

PA2BG

NOMESCO Finland

MRI examination of vessels in the head with high intensity magnet

4.2

27.6

175

Z00.0

ICD-10 Finland

General medical examination

1.4

27.5

1596

12124

N05AD03

ATC

melperone; systemic

3.0

27.5

121

406

R60.0

ICD-10 Finland

Localized oedema

1.5

27.4

970

6745

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.5

27.4

841

5678

G31.2

ICD-10 Finland

Degeneration of nervous system due to alcohol

4.1

27.3

185

J01EA01

ATC

trimethoprim; systemic

1.3

27.3

2015

15880

9694A

ICD-9 Finland

Poisoning by psychotropic agents, Benzodiazepine-based tranquillisers

4.3

27.3

164

Z02.7

ICD-10 Finland

Issue of medical certificate

1.6

27.1

580

3598

3458X

ICD-9 Finland

Epilepsy, Other forms of epilepsy

+∞

27.1

F06.0

ICD-10 Finland

Organic hallucinosis

7.4

27.1

C02AC05

ATC

moxonidine; oral

1.9

26.9

368

2010

JN4BD

NOMESCO Finland

Extensive body CT

1.5

26.9

814

5477

C71.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of brain

41.3

26.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

1.7

26.7

489

2912

I60.7

ICD-10 Finland

Subarachnoid haemorrhage from intracranial artery, unspecified

5.5

26.7

A07

ICPC

Coma

5.1

26.5

108

N06AX03

ATC

mianserin; oral

1.8

26.5

371

2042

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.3

26.5

2545

20791

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.9

26.5

351

1899

E87.0

ICD-10 Finland

Hyperosmolality and hypernatraemia

5.3

26.4

101

D21

ICPC

Swallowing problem

2.7

26.4

140

520

G43.9

ICD-10 Finland

Migraine, unspecified

1.7

26.4

450

2628

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

4.6

26.3

132

9450/3-C71.9

ICD-O-3

Oligodendroglioma, NOS, of brain, NOS

+∞

26.0

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

26.0

230

1078

OAB48, ,

SPAT

0.6

25.9

490

7870

D33.9

ICD-10 Finland

Benign neoplasm: Central nervous system, unspecified

9.7

25.8

N05BA02

ATC

chlordiazepoxide; systemic

2.3

25.8

196

863

RS122, ,

NOMESCO Finland

5.5

25.8

E16.2

ICD-10 Finland

Hypoglycaemia, unspecified

2.9

25.7

123

433

E86

ICD-10 Finland

Volume depletion

2.2

25.5

212

968

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

1.5

25.4

938

6571

PA2KT

NOMESCO Finland

Endovascular closure of brain aneurysm

7.1

25.4

F44.9

ICD-10 Finland

Dissociative [conversion] disorder, unspecified

4.4

25.4

140

G91.2

ICD-10 Finland

Normal-pressure hydrocephalus

2.9

25.3

120

420

J01DB01

ATC

cefalexin; oral

1.3

25.3

7581

70682

W10

ICD-10 Finland

Fall on and from stairs and steps

1.8

25.3

423

2457

XXA00

NOMESCO Finland

Clinical examination requiring general anaesthesia

3.9

25.2

192

SPAT1221

SPAT

Guidance concerning rehabilitation services and livelihood

2.5

25.2

164

674

ZX095

NOMESCO Finland

Combined chemoradiotherapy

3.9

25.0

184

C07AA05

ATC

propranolol; systemic

1.4

25.0

1565

12016

C71.40

ICD-10 Finland

Malignant tumor of the occipital lobe without histology

58.1

25.0

R2120

NOMESCO Finland

Counselling and guidance concerning rehabilitation services and social security

3.4

24.9

254

F06.2

ICD-10 Finland

Organic delusional [schizophrenia-like] disorder

8.4

24.8

SPAT1296

SPAT

Other function in accordance with occupational therapy nomenclature

2.9

24.6

114

394

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

2.6

24.5

144

564

C07AB07

ATC

bisoprolol; oral

1.2

24.5

3932

34106

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.9

24.5

325

1760

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

1.7

24.4

491

2998

D64.9

ICD-10 Finland

Anaemia, unspecified

1.5

24.4

839

5794

PA2LT

NOMESCO Finland

Endovascular closure of extensive brain aneurysm

5.6

24.4

N05AF05

ATC

zuclopenthixol; systemic

3.4

24.3

253

F07.2

ICD-10 Finland

Postconcussional syndrome

8.2

24.3

R26.8

ICD-10 Finland

Other and unspecified abnormalities of gait and mobility

2.3

24.3

181

790

K59.09

ICD-10 Finland

Constipation, unspecified

1.6

24.3

542

3398

S06.9

ICD-10 Finland

Intracranial injury, unspecified

3.7

24.3

211

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

1.5

24.2

736

4954

XFP96

NOMESCO Finland

Other intraoperative electrophysiological investigation in arhythmia or disturbance of impulse propagation

2.3

24.1

175

755

S02.00

ICD-10 Finland

Fracture of the upper part of the head closed

4.9

24.1

106

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.7

24.0

503

3105

AAJ10

NOMESCO Finland

Lobectomy for epilepsy

+∞

24.0

Y57

ICD-10 Finland

Adverse effects in the therapeutic use of other and unspecified drugs and medicaments

2.3

23.9

179

783

SPAT1260

SPAT

Consultation of another employee

1.4

23.9

1403

10660

C79.31

ICD-10 Finland

Secondary malignant tumor of the cerebellum

6.4

23.8

SPAT1295

SPAT

Other function in accordance with physical therapy nomenclature

1.8

23.8

392

2266

S72.0

ICD-10 Finland

Fracture of neck of femur

1.9

23.8

316

1711

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

2.2

23.8

192

867

SPAT1263

SPAT

Sampling

1.3

23.7

3543

30446

G44.2

ICD-10 Finland

Tension-type headache

1.4

23.7

1035

7477

7840A

ICD-9 Finland

Symptoms involving head and neck, Headache

3.2

23.7

297

S32.0

ICD-10 Finland

Fracture of lumbar vertebra

2.0

23.6

257

1302

Z43.0

ICD-10 Finland

Attention to tracheostomy

9.4

23.5

ZXE17

NOMESCO Finland

Procedure duration 150 to 179 minutes

2.9

23.4

109

378

AAK80

NOMESCO Finland

Partial excision of skull cap

19.5

23.4

RT150, ,

NOMESCO Finland

4.5

23.3

125

R33

ICD-10 Finland

Retention of urine

1.6

23.2

637

4192

85190

ICD-8 Finland

Cerebral laceration and contusion, Late effect

9.7

23.2

TAA40

NOMESCO Finland

Cathetrisation of cerebrospinal fluid through skin

6.2

23.1

ZXA05

NOMESCO Finland

Left side

1.3

23.1

1931

15445

SPAT1172

SPAT

Guidance concerning hydration

2.2

23.0

192

879

G05.1*B00.4

ICD-10 Finland

Herpesviral meningoencephalitis

18.5

23.0

CS424

NOMESCO Finland

Visual field testing with Goldmann perimetry

3.1

23.0

298

SPAT1304

SPAT

Counselling and guidance related to ageing

1.6

22.9

531

3361

RS211, ,

NOMESCO Finland

4.4

22.8

127

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.6

22.8

539

3427

FPK00

NOMESCO Finland

Implantation of electrocardiograph with loop recorder

3.8

22.8

183

A46

ICD-10 Finland

Erysipelas

1.4

22.8

1144

8469

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.3

22.6

1450

11162

AAU00

NOMESCO Finland

Removal of implant or external fixation device from skull

120.2

22.6

EBA00

NOMESCO Finland

Extraction of tooth

1.3

22.5

2977

25195

K59.0

ICD-10 Finland

Constipation

1.7

22.5

452

2760

I60.2

ICD-10 Finland

Subarachnoid haemorrhage from anterior communicating artery

4.2

22.4

137

G93.4

ICD-10 Finland

Encephalopathy, unspecified

6.0

22.4

AA1AA

NOMESCO Finland

Head X-ray examination

3.2

22.4

267

XX9BW

NOMESCO Finland

Submitting image material and/or investigation material to authority or other institution

2.9

22.4

107

377

WC105

NOMESCO Finland

Simple cytostatic therapy of local tumor recidive

4.7

22.3

109

C10AA01

ATC

simvastatin; oral

1.2

22.2

3263

27933

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

1.8

22.1

331

1861

XX1FW

NOMESCO Finland

Written report from MRI examination performed elsewhere

17.9

22.1

TPX22

NOMESCO Finland

Intravenous arterial thrombolysis

3.2

22.1

264

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

1.9

22.0

275

1460

RS121, ,

NOMESCO Finland

3.5

22.0

211

SPAT1167

SPAT

Insertion of urinary catheter

1.9

22.0

259

1349

M01AH05

ATC

etoricoxib; oral

0.8

21.9

4056

45677

34531

ICD-8 Finland

Epilepsy, Patrialis (focalis) Jackson

+∞

21.9

JDB10

NOMESCO Finland

Percutaneous gastrostomy

2.7

21.9

113

415

F06.7

ICD-10 Finland

Mild cognitive disorder

2.0

21.9

226

1124

H55

ICD-10 Finland

Nystagmus and other irregular eye movements

4.5

21.9

119

PA2VT

NOMESCO Finland

Intravascular evacuation of brain artery embolus

4.0

21.8

153

F60.9

ICD-10 Finland

Personality disorder, unspecified

2.7

21.8

115

427

I67.9

ICD-10 Finland

Cerebrovascular disease, unspecified

3.1

21.8

287

D33.05

ICD-10 Finland

Other lateral benign tumor in temporal lobe

25.0

21.7

OAA80, ,

SPAT

0.5

21.7

253

4639

F00.00*G30.0

ICD-10 Finland

Primary degenerative dementia of the Alzheimer's type, presenile onset without additional symptoms

3.7

21.6

181

F41.09

ICD-10 Finland

UNS Panic Syndrome

2.0

21.5

235

1192

F43.21

ICD-10 Finland

Adaptation disorder with prolonged depression

3.1

21.5

284

P15

ICPC

Chronic alcohol abuse

2.0

21.5

234

1186

N06AX22

ATC

agomelatine; oral

2.2

21.5

183

846

F72.0

ICD-10 Finland

Severe mental retardation, with the statement of no, or minimal, impairment of behaviour

31.2

21.4

FP1B5

NOMESCO Finland

Resting ECG, 12 leads

2.3

21.3

166

739

S01.9

ICD-10 Finland

Open wound of head, part unspecified

2.3

21.3

159

695

S72.1

ICD-10 Finland

Pertrochanteric fracture

2.2

21.3

178

816

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

1.6

21.3

496

3143

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

2.9

21.3

344

S82.6

ICD-10 Finland

Fracture of lateral malleolus

1.6

21.2

468

2925

G80.0

ICD-10 Finland

Spastic quadriplegic cerebral palsy

20.7

21.2

AAF99

NOMESCO Finland

Other shunt operation on ventricle of brain or intracerebral cyst

7.2

21.1

C71.83

ICD-10 Finland

Overall malignant tumor of the brain grade IV glioma

50.1

21.1

D33.08

ICD-10 Finland

Another benign tumor of the cerebral ventricle

33.8

21.1

R13

ICD-10 Finland

Dysphagia

1.6

21.0

522

3358

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

1.7

21.0

357

2084

M41.4

ICD-10 Finland

Neuromuscular scoliosis

8.5

21.0

RS230, ,

NOMESCO Finland

3.8

21.0

162

N30.9

ICD-10 Finland

Cystitis, unspecified

1.6

20.9

464

2905

N06AB03

ATC

fluoxetine; oral

1.4

20.9

907

6542

SPAT1305

SPAT

Counselling and guidance related to physical exercise

1.5

20.9

709

4881

C79.3

ICD-10 Finland

Secondary malignant neoplasm of brain and cerebral meninges

8.0

20.8

C71.39

ICD-10 Finland

Malignant tumor of parietal lobe other or unspecified histology

60.1

20.8

34300

ICD-8 Finland

Cerebral spastic infantile paralysis, Hemiplegia spastica

60.1

20.8

AA5FK

NOMESCO Finland

Functional assessment (fMRI) of brain

+∞

20.8

EBA15

NOMESCO Finland

Extraction of multiple teeth

1.8

20.7

315

1779

NB6AA

NOMESCO Finland

Humerus X-ray examination

2.2

20.7

177

819

I61.4

ICD-10 Finland

Intracerebral haemorrhage in cerebellum

6.0

20.7

96610

ICD-8 Finland

Adverse effect of anticonvulsants, Hydantoin derivatives

76.9

20.7

F61.0

ICD-10 Finland

Mixed personality disorders

2.4

20.7

140

587

307

Kela drug reimbursment

Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease

1.8

20.6

292

1614

W06

ICD-10 Finland

Fall involving bed

3.3

20.6

240

ZXA00

NOMESCO Finland

Right side

1.3

20.5

2044

16692

J01DA01

ATC

[U] cefalexin

1.2

20.5

5241

47400

SPAT1210

SPAT

Application of cast or individual aid

1.8

20.4

313

1773

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

1.9

20.4

262

1405

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

20.3

523

3392

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.9

20.3

242

1266

R62.0

ICD-10 Finland

Delayed milestone

3.3

20.2

233

SPAT1306

SPAT

Counselling and guidance related to nutrition and weight management

1.4

20.2

1034

7672

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.6

20.1

539

3528

N05BA12

ATC

alprazolam; oral

1.5

20.1

732

5108

S42.0

ICD-10 Finland

Fracture of clavicle

1.9

20.0

232

1203

SPAT1250

SPAT

Comprehensive monitoring of chronic illness

1.3

19.9

2002

16355

J01CA08

ATC

pivmecillinam; oral

1.2

19.9

2943

25140

M05BA04

ATC

alendronic acid; oral

1.5

19.9

599

4022

XX3XW, ,

NOMESCO Finland

3.5

19.9

187

A99

ICPC

Disease/condition unspecnature/site

1.5

19.8

706

4905

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

19.8

3221

27793

N03AF03

ATC

rufinamide; oral

+∞

19.8

9401/3-C71.9

ICD-O-3

Astrocytoma, anaplastic, NOS, of brain, NOS

+∞

19.8

C71.82

ICD-10 Finland

Overall malignant tumor of the brain grade III glioma

+∞

19.8

9451/3-C71.1

ICD-O-3

Oligodendroglioma, anaplastic, NOS, of frontal lobe

+∞

19.8

N06DA03

ATC

rivastigmine; oral, transdermal

1.8

19.8

316

1812

ZXD10

NOMESCO Finland

Scheduled procedure

1.2

19.7

3084

26499

G04.8

ICD-10 Finland

Other encephalitis, myelitis and encephalomyelitis

15.3

19.7

9440/3-C71.3

ICD-O-3

Glioblastoma, NOS, of parietal lobe

73.6

19.7

WZC30

NOMESCO Finland

Teaching

1.4

19.7

1197

9127

Z29

ICPC

Social problem NOS

2.1

19.6

180

857

Z3229

NOMESCO Finland

Other healthcare associate professional

1.5

19.6

667

4593

R56

ICD-10 Finland

Convulsions, not elsewhere classified

28.9

19.6

C71.80

ICD-10 Finland

Overall malignant tumor of the brain without histology

28.9

19.6

9382/3-C71.1

ICD-O-3

Oligoastrocytoma, NOS, of frontal lobe

200.3

19.5

I60.3

ICD-10 Finland

Subarachnoid haemorrhage from posterior communicating artery

7.4

19.5

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.6

19.5

431

2698

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

2.8

19.4

356

Z08

ICPC

Social welfare problem

2.6

19.4

112

436

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.6

19.4

504

3278

WX725

NOMESCO Finland

Noninvasive ventilation

1.6

19.3

408

2523

E87.8

ICD-10 Finland

Other disorders of electrolyte and fluid balance, not elsewhere classified

6.1

19.3

G04BD04

ATC

oxybutynin; oral, transdermal

1.7

19.3

386

2355

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

1.6

19.3

401

2471

G30.0

ICD-10 Finland

Alzheimer disease with early onset

3.1

19.2

266

N05BE01

ATC

buspirone; oral

2.0

19.2

221

1142

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.5

19.2

708

4953

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.1

19.2

174

825

I69.4

ICD-10 Finland

Sequelae of stroke, not specified as haemorrhage or infarction

7.9

19.1

9531/0-C70.0

ICD-O-3

Meningothelial meningioma of cerebral meninges

16.7

19.1

F43.29

ICD-10 Finland

Adaptation disorder UNS

2.1

19.1

181

873

XF404

NOMESCO Finland

Ambulatory ECG

1.5

19.0

672

4662

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

3.6

18.8

170

SPAT1251

SPAT

Organisation of medication

1.8

18.8

276

1544

3456B

ICD-9 Finland

Epilepsy, Infantile spasms[EPILEPSIA MYOCLONICA CUM ASTASIA]

+∞

18.7

AA11X, ,

NOMESCO Finland

+∞

18.7

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

2.7

18.7

369

D42.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Cerebral meninges

17.1

18.6

4340A

ICD-9 Finland

Occlusion of cerebral arteries, Cerebral thrombosis

3.0

18.6

266

C71

ICD-10 Finland

Malignant neoplasm of brain

100.2

18.5

AAA40

NOMESCO Finland

Insertion of intracerebral electrodes

190.2

18.5

D32.07

ICD-10 Finland

Secondary or multiple benign tumor of the meninges below the exam

14.1

18.5

F81.8

ICD-10 Finland

Other developmental disorders of scholastic skills

5.0

18.5

G43.3

ICD-10 Finland

Complicated migraine

2.4

18.5

129

549

S70.0

ICD-10 Finland

Contusion of hip

1.8

18.4

299

1723

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

1.4

18.4

945

7011

SPAT1153

SPAT

Removal of sutures

1.2

18.4

2442

20584

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

2.7

18.4

344

K92.0

ICD-10 Finland

Haematemesis

2.0

18.3

196

989

U07.2

ICD-10 Finland

COVID-19, virus not identified

0.7

18.3

940

12455

F40.9

ICD-10 Finland

Phobic anxiety disorder, unspecified

3.8

18.2

146

YX8AD

NOMESCO Finland

Stereotactic CT examination for dose design of radiotherapy

7.1

18.2

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

1.6

18.2

470

3052

H53.1

ICD-10 Finland

Subjective visual disturbances

1.5

18.2

504

3325

N02BF02

ATC

pregabalin; oral

1.6

18.2

421

2665

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.2

18.2

2967

25561

N27

ICPC

Fear of neurological disease other

2.3

18.1

132

572

N06AG02

ATC

moclobemide; oral

1.7

18.1

310

1813

WF004

NOMESCO Finland

Palliative radiotherapy

2.1

18.1

165

784

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

1.9

18.1

209

1083

2968A

ICD-9 Finland

Affective psychoses, Manic-depressive psychosis, other and unspecified

2.9

18.1

303

K08.3

ICD-10 Finland

Retained dental root

1.5

18.0

569

3858

ZY000

NOMESCO Finland

Hospital inpatient

2.5

18.0

110

440

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

2.8

18.0

331

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.5

18.0

566

3835

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

1.5

18.0

590

4033

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

2.8

17.9

321

ZX120

NOMESCO Finland

Intravenous

1.4

17.8

715

5080

F82

ICD-10 Finland

Specific developmental disorder of motor function

3.7

17.8

153

G96.0

ICD-10 Finland

Cerebrospinal fluid leak

7.6

17.8

3431A

ICD-9 Finland

Infantile cerebral palsy, Hemiplegic

26.7

17.8

9380/3-C71.9

ICD-O-3

Glioma, malignant of brain, NOS

26.7

17.8

WZA90

NOMESCO Finland

Other medical or dental certificate

1.3

17.7

1842

15084

34509

ICD-8 Finland

Epilepsy, Absentia epileptica NUD

+∞

17.7

S00.1

ICD-10 Finland

Contusion of eyelid and periocular area

2.1

17.7

173

845

SPAT1101

SPAT

Orthostatic test

1.7

17.7

323

1925

S02.10

ICD-10 Finland

Fracture of base of skull, closed

4.1

17.6

114

L89

ICD-10 Finland

Decubitus ulcer and pressure area

2.2

17.6

148

682

Z46.8

ICD-10 Finland

Fitting and adjustment of other specified devices

2.0

17.6

202

1045

S01.1

ICD-10 Finland

Open wound of eyelid and periocular area

1.9

17.6

211

1108

96698

ICD-8 Finland

Other antiepileptics

95.2

17.5

F34.1

ICD-10 Finland

Dysthymia

1.8

17.5

263

1482

N05AN01

ATC

lithium; oral

2.0

17.5

181

902

F54

ICD-10 Finland

Psychological and behavioural factors associated with disorders or diseases classified elsewhere

4.0

17.5

119

5AB01, ,

NOMESCO Finland

6.5

17.4

78259

ICD-8 Finland

Symptoms referable to cardiovascular and lymphatic system, Syncope (lipothymia) alia sive NUD

5.5

17.4

P76

ICPC

Depressive disorder

1.5

17.3

469

3078

G30.1

ICD-10 Finland

Alzheimer disease with late onset

1.6

17.3

434

2799

9537/0-C70.0

ICD-O-3

Transitional meningioma of cerebral meninges

20.9

17.2

SPAT1310

SPAT

Counselling related to known health issue

1.2

17.2

2522

21457

S22.0

ICD-10 Finland

Fracture of thoracic vertebra

2.1

17.2

159

760

N06AX21

ATC

duloxetine; oral

1.4

17.0

833

6127

P03

ICPC

Feeling depressed

1.4

16.9

736

5305

S06.8

ICD-10 Finland

Other intracranial injuries

5.9

16.9

G93.6

ICD-10 Finland

Cerebral oedema

25.6

16.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.2

16.8

3428

30129

N06AB05

ATC

paroxetine; oral

1.6

16.8

414

2661

F05.0

ICD-10 Finland

Delirium not superimposed on dementia, so described

4.6

16.7

SPAT1050

SPAT

Extensive neurological examination

2.0

16.7

171

849

L27.0

ICD-10 Finland

Generalized skin eruption due to drugs and medicaments

2.5

16.7

105

426

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

1.7

16.7

307

1833

PA7ST

NOMESCO Finland

Extensive medical infusion to cerebral artery

35.0

16.6

RS142, ,

NOMESCO Finland

5.0

16.6

F07.8

ICD-10 Finland

Other organic personality and behavioural disorders due to brain disease, damage and dysfunction

15.0

16.6

S20.2

ICD-10 Finland

Contusion of thorax

1.6

16.6

392

2493

RT490, ,

NOMESCO Finland

12.6

16.6

R4120, ,

SPAT

2.8

16.6

279

SPAT1104

SPAT

Monitoring of emergency patient

1.5

16.6

491

3287

9400/3-C71.2

ICD-O-3

Astrocytoma, NOS, of temporal lobe

90.2

16.5

E22.2

ICD-10 Finland

Syndrome of inappropriate secretion of antidiuretic hormone

6.7

16.5

D33.02

ICD-10 Finland

Another benign medial tumor of the cerebrum

16.3

16.5

G40.5

ICD-10 Finland

Special epileptic syndromes

170.2

16.5

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

1.8

16.5

256

1458

N06DX01

ATC

memantine; oral

1.5

16.5

522

3544

PA4AC

NOMESCO Finland

Vertebralis angiography with X-ray

5.5

16.4

E10.00

ICD-10 Finland

Insulin-dependent diabetes diabetic hypoglycemic coma

2.6

16.4

359

C71.9

ICD-10 Finland

Malignant neoplasm: Brain, unspecified

17.9

16.4

C09AA05

ATC

ramipril; oral

1.3

16.4

1874

15503

9680/3-C71.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of brain, NOS

20.0

16.4

SPAT1033

SPAT

Irrigation or wax removal of outer auditory canal

1.3

16.3

1397

11155

AAL10

NOMESCO Finland

Intracranial endovascular thrombolysis

3.4

16.3

172

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

2.0

16.3

169

843

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

2.0

16.3

185

953

N03AA03

ATC

primidone; oral

5.3

16.3

I63

ICD-10 Finland

Cerebral infarction

2.9

16.3

249

RS340, ,

NOMESCO Finland

4.7

16.3

Z2221

NOMESCO Finland

Medical doctor

1.2

16.3

2161

18176

N05AB01

ATC

dixyrazine; systemic

2.6

16.3

361

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

2.2

16.2

134

613

R1100

NOMESCO Finland

General evaluation of the need for rehabilitation

2.3

16.2

126

562

F43.20

ICD-10 Finland

Adaptation disorder with short-term depression

2.4

16.2

107

445

ZXM20

NOMESCO Finland

Intraoperative use of computerised tomography

3.0

16.2

229

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

2.0

16.2

162

799

G80.8

ICD-10 Finland

Other cerebral palsy

30.0

16.1

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.4

16.0

680

4880

N75

ICPC

Benign neoplasm nervous system

16.7

16.0

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

1.8

16.0

229

1272

SPAT1279

SPAT

Preparation of immediate hospitalisation

2.7

16.0

318

AAD00

NOMESCO Finland

Evacuation of epidural haematoma

18.5

16.0

N31.9

ICD-10 Finland

Neuromuscular dysfunction of bladder, unspecified

2.8

15.9

269

SPAT1262

SPAT

Handing over of treatment supplies

1.3

15.9

1318

10482

RS313, ,

NOMESCO Finland

4.6

15.8

G91.8

ICD-10 Finland

Other hydrocephalus

14.5

15.8

C71.89

ICD-10 Finland

Overall malignant tumor of the brain other or unspecified histology

33.4

15.7

Z63.7

ICD-10 Finland

Other stressful life events affecting family and household

2.1

15.7

142

674

V03AA01, ,

ATC

2.3

15.7

118

520

F81.3

ICD-10 Finland

Mixed disorder of scholastic skills

3.6

15.7

143

9401/3-C71.2

ICD-O-3

Astrocytoma, anaplastic, NOS, of temporal lobe

+∞

15.6

3457B

ICD-9 Finland

Epilepsy, Epilepsia partialis continua[EPILEPSIA PARTIALIS CONTINUA]

+∞

15.6

199

Kela drug reimbursment

Rufinamide

+∞

15.6

XX9WW, ,

NOMESCO Finland

+∞

15.6

N06AA09

ATC

amitriptyline; systemic

1.4

15.6

661

4744

B94.1

ICD-10 Finland

Sequelae of viral encephalitis

26.3

15.6

NC2AA

NOMESCO Finland

Forearm X-ray examination

2.3

15.5

118

522

WF029

NOMESCO Finland

Radiotherapy of local residive tumor

3.3

15.5

178

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

1.3

15.5

963

7355

Z60.8

ICD-10 Finland

Other problems related to social environment

4.3

15.4

R29.6

ICD-10 Finland

Tendency to fall, not elsewhere classified

3.7

15.4

126

Z72.8

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

749

1663

4.78

313.27

1.6

1.7

22.92

22.15

e6/l

0.04

601

1258

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

748

1663

4.77

312.32

1.7

1650.53

3153.49

e6/l

0.29

628

1328

(3044290) Cell count panel - Cerebral spinal fluid

720

1552

4.92

312.04

1.6

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

2133

8858

2.78

307.65

7.6

7.3

13.98

12.37

kpa

24.21

2038

8412

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

6071

39162

2.37

307.65

8.4

6.9

1.20

1.21

mmol/l

31.00

5331

33334

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

5202

23216

3.55

307.65

3.5

2.1

223.88

215.77

u/l

0.17

5044

21727

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

277

101.63

307.65

3.4

2.9

42.30

37.47

umol/l

0.38

253

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

822

114.56

307.65

3.3

2.1

29.95

27.25

umol/l

0.85

626

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

5740

35506

2.42

307.65

7.6

6.3

1.20

1.21

mmol/l

35.03

5436

32423

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

1080

2617

4.50

307.65

2.3

2.4

357.57

539.93

ug/l

1.17

1026

2459

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2133

8862

2.78

307.65

7.6

7.3

5.04

5.08

kpa

1.38

2040

8420

(3009466) Valproate [Moles/volume] in Serum or Plasma

1667

742

26.69

307.65

3.9

5.7

369.74

362.11

umol/l

0.66

1468

629

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

512

664

8.06

307.65

1.7

1.4

—

(3003396) Base excess in Arterial blood by calculation

2129

8832

2.78

307.65

7.7

7.3

1.14

0.99

mmol/l

1.05

1662

6926

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

786

1661

5.04

307.65

1.4

1.6

3.87

3.72

mmol/l

2.74

742

1554

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2834

12261

2.82

307.65

2.3

28.96

30.00

12.93

2752

11883

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1381

363.14

307.65

2.6

2.2

54.77

35.74

umol/l

2.83

1216

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

861

1890

4.88

307.65

1.5

1.6

543.54

507.56

mg/l

1.01

826

1795

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

475

441

11.25

307.65

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

6608

46986

2.17

285.73

7.3

4.7

6.60

6.70

mmol/l

3.43

6354

43796

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

133

70.88

245.29

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

662

1623

4.29

243.13

2.9

2.8

31.63

34.39

umol/l

2.06

596

1469

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

374

557

6.93

238.91

1.4

1.2

2.22

1.99

mmol/l

2.33

347

517

(3022217) INR in Platelet poor plasma by Coagulation assay

5337

36534

1.97

236.55

15.9

15.3

1.22

1.28

inr

4.18

1507

10637

(3023368) Bacteria identified in Blood by Culture

3578

21564

2.02

226.47

4.7

4.3

—

(3016502) Oxygen saturation in Arterial blood

1750

7955

2.45

224.35

8.5

7.7

96.02

95.64

1.52

1685

7635

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1645

7293

2.50

222.53

8.7

8.0

123.28

121.68

g/l

2.55

1605

7084

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

300

395

7.79

213.89

1.2

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

292

383

7.82

208.85

1.2

1.1

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

4383

29371

1.87

194.00

4.9

3.6

45.50

82.47

ng/l

0.97

3354

19762

(3018418) pH of Serum or Plasma

3625

22878

1.91

193.29

4.2

4.1

7.40

0.58

683

4377

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2346

12810

2.08

189.16

4.0

3.8

0.81

0.82

mmol/l

1.62

2190

12007

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

274

376

7.46

188.35

1.6

1.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2320

12785

2.06

181.47

2.0

1.8

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1265

5435

2.52

180.56

7.0

8.5

24.38

24.77

mmol/l

3.89

1255

5395

(3020191) Ethanol [Moles/volume] in Serum or Plasma

340

622

5.62

176.43

1.9

1.4

0.74

1.43

promille

11.89

280

478

(3016018) Differential panel - Cerebral spinal fluid

397

841

4.87

174.45

1.5

1.7

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1022

4109

2.65

166.71

7.3

9.8

24.23

24.24

mmol/l

0.06

1000

3963

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1140

4835

2.53

166.56

10.0

6.6

24.68

24.48

mmol/l

0.96

1089

4588

(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

84.65

158.61

1.1

1.0

—

(3003181) Sodium [Moles/volume] in Urine

479

1276

3.89

156.12

1.5

71.07

64.67

mmol/l

2.10

395

1031

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1120

4874

2.46

154.27

8.1

9.4

0.73

0.67

5.43

1113

4839

(3014111) Lactate [Moles/volume] in Serum or Plasma

1445

7025

2.23

154.04

6.5

7.4

1.44

1.36

mmol/l

1.78

1408

6817

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1120

4893

2.45

152.90

8.1

9.3

1.42

1.37

0.57

1111

4861

(3019060) Gas panel - Arterial blood

1151

5096

2.42

152.55

7.2

4.5

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

4715

34093

1.72

147.42

5.6

5.0

34.90

35.60

g/l

13.21

4424

31644

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1672

8759

2.09

146.64

1.9

1.7

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1469

7333

2.17

146.05

2.4

2.2

369.43

371.43

nmol/l

0.14

1350

6742

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

189

228

8.42

144.83

1.2

1.1

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1668

8785

2.07

143.97

1.9

1.8

—

(3026008) Bacteria identified in Urine by Culture

3497

23611

1.73

137.65

3.6

3.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

5359

40858

1.66

131.17

8.0

6.2

9.86

11.89

umol/l

27.71

5069

38706

(3000991) Gas panel - Venous blood

1400

7169

2.10

129.17

7.2

8.8

—

(3018405) Lactate [Moles/volume] in Arterial blood

701

2704

2.71

122.99

4.8

3.9

1.50

1.38

mmol/l

1.42

692

2658

(3033658) Prothrombin time (PT) actual/Normal

3063

20430

1.71

122.92

4.7

4.2

89.44

88.99

0.45

2984

19930

(3023410) Appearance of Cerebral spinal fluid

331

803

4.23

122.42

1.7

2.2

—

(3043409) Potassium [Moles/volume] in Arterial blood

623

2289

2.83

119.92

5.2

4.1

3.87

3.90

mmol/l

0.58

617

2266

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1476

7958

2.00

117.42

4.2

4.6

5.89

5.83

kpa

1.77

1433

7721

(3002032) Base excess in Venous blood by calculation

1465

7929

1.99

115.11

4.2

4.6

1.93

1.80

mmol/l

0.77

1261

6651

(3020891) Body temperature

753

3119

2.53

114.07

5.9

4.7

—

(3024354) Oxygen [Partial pressure] in Venous blood

1274

6610

2.06

112.45

4.0

4.2

4.67

kpa

0.01

1234

6397

(3015377) Calcium [Moles/volume] in Serum or Plasma

3650

26044

1.63

110.05

4.2

3.3

2.34

2.35

mmol/l

12.41

3229

22920

(3012544) pH of Venous blood

1485

8216

1.95

108.98

4.2

4.6

7.37

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

957

4651

2.17

99.71

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

174

292

6.04

98.72

1.2

1.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

150

222

6.84

96.18

1.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

2249

14593

1.69

95.79

1.8

1.7

1191.46

1161.71

nmol/l

0.85

1777

11005

(3031040) Bacteria [#/volume] in Urine by Automated count

6383

52903

1.56

94.45

5.7

4.4

2613.98

1770.11

e6/l

0.42

113

727

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1765

10742

1.78

94.40

5.6

6.4

1.03

1.06

mmol/l

4.49

1638

10003

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

140

198

7.15

93.60

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

145

214

6.86

93.22

1.2

1.0

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

146

218

6.78

92.85

1.1

—

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

187

361

5.26

91.35

1.6

1.2

47.68

70.44

2.58

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

145

219

6.70

91.23

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

5752

46804

1.53

90.80

11.6

9.1

4.07

4.11

e9/l

0.63

5055

40725

(3006315) Basophils [#/volume] in Blood

5122

40919

1.51

86.29

7.0

6.1

0.04

e9/l

12.55

4449

35305

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

273

742

3.75

86.17

1.1

1.0

—

(3001604) Monocytes [#/volume] in Blood

5107

40816

1.51

85.58

7.0

6.1

0.60

0.59

e9/l

0.40

4447

35230

(3013115) Eosinophils [#/volume] in Blood

5252

42255

1.50

84.96

7.3

6.3

0.17

0.20

e9/l

15.79

4611

37020

(3019198) Lymphocytes [#/volume] in Blood

5230

42073

1.50

84.43

7.1

6.1

1.84

1.94

e9/l

2.34

4622

37158

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1571

9540

1.76

83.71

10.0

7.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

7100

60961

1.55

83.59

9.5

7.4

81.06

79.50

u/l

1.70

6730

57453

(3020779) Urea [Moles/volume] in Serum or Plasma

1300

7482

1.85

82.79

6.5

7.8

7.88

9.72

mmol/l

19.97

1232

7142

(40760892) CBC W Ordered Manual Differential panel - Blood

4837

38393

1.50

82.70

7.5

6.6

—

(3036489) Thrombin time

675

3073

2.28

82.08

2.4

2.7

21.39

21.69

0.54

615

2690

(3044640) Blood type and Crossmatch panel - Blood

3445

25528

1.53

81.66

2.7

2.4

—

(3008295) Osmolality of Serum or Plasma

277

797

3.54

80.33

1.4

1.5

277.54

281.42

mosm/kgh2o

1.63

205

619

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

761

3676

2.16

79.92

3.6

3.3

1.35

1.26

1.30

756

3653

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

12.46

79.39

1.2

1.0

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

9.86

78.28

1.2

1.1

—

(3026782) Osmolality of Urine

2374

16354

1.59

77.09

3.1

2.9

543.00

549.23

mosm/kgh2o

0.67

2072

14050

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1183

6758

1.85

76.80

2.6

2.3

5.77

7.36

ug/l

3.14

1020

5851

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

839

4268

2.05

76.76

11.1

9.9

—

(3051593) INR in Capillary blood by Coagulation assay

165

334

5.00

76.38

4.4

12.2

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

910

4780

1.99

76.10

3.9

3.8

129.54

129.45

g/l

0.04

893

4661

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

9.74

75.02

1.2

1.1

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

154

301

5.18

74.21

1.2

1.1

676.81

378.75

ng/l

0.21

(3027273) Bicarbonate [Moles/volume] in Venous blood

754

3766

2.08

72.35

3.8

3.6

25.19

25.20

mmol/l

0.02

733

3643

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

711

3492

2.11

71.31

4.5

4.3

50.82

48.45

1.84

703

3448

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

985

5458

1.89

70.05

4.7

4.4

1.59

1.65

mmol/l

0.18

730

4001

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

3294

24772

1.49

70.03

3.1

2.6

57.53

63.06

u/l

0.83

3066

22931

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1016

5701

1.87

69.45

4.7

4.4

5.22

5.13

kpa

2.91

957

5417

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

868

4629

1.96

69.23

1.7

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2052

13988

1.58

68.53

3.1

3.0

2.43

2.45

mmol/l

7.62

1799

12175

(3009343) pH of Capillary blood

1002

5633

1.86

68.02

4.7

4.5

7.42

7.41

0.46

115

630

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

655

3197

2.12

66.67

8.6

4.8

1.77

1.65

1.49

612

2979

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

168

6.48

66.10

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

103

153

6.79

65.86

1.1

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

648

3165

2.12

65.82

8.8

4.9

0.92

0.89

1.01

605

2953

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

225

648

3.53

65.17

1.2

39.95

40.86

mg/l

0.12

193

536

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

219

626

3.55

64.16

1.1

264.04

259.25

mg/l

0.13

200

549

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

2659

19510

1.49

62.33

2.5

2.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

3390

26114

1.45

61.70

4.2

3.3

31.83

34.32

u/l

0.97

3207

24722

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

9.19

61.19

1.1

—

(3022096) Basophils/100 leukocytes in Blood

4550

37188

1.41

58.46

7.1

6.3

0.63

0.67

6.59

4280

34703

(3016038) Potassium [Moles/volume] in Urine

187

512

3.70

58.44

1.4

33.45

35.35

mmol/l

0.50

160

450

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

155

6.31

57.86

1.1

1.4

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

203

593

3.47

57.55

1.1

—

(4035726) Immunohistochemistry procedure

1109

6740

1.72

57.36

1.4

—

(3006504) Eosinophils/100 leukocytes in Blood

4664

38400

1.40

56.78

7.2

6.3

2.61

2.89

13.31

4388

35903

(3019069) Monocytes/100 leukocytes in Blood

4686

38612

1.40

56.78

7.5

6.6

8.92

8.59

9.52

4408

36158

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

253

858

3.00

56.07

1.5

1.7

—

(3019150) Specific gravity of Urine by Refractometry

2369

17296

1.48

55.85

5.0

3.9

1.02

kg/l

0.17

336

2644

(3021960) Folate [Moles/volume] in Serum or Plasma

2435

17878

1.48

55.79

1.7

1.5

18.41

20.16

nmol/l

7.66

2170

15373

(1761868) Lipid panel - Serum or Plasma

2078

28191

0.67

55.57

2.8

2.7

—

(3039000) Anion gap in Blood

401

1734

2.37

54.68

11.8

6.5

11.03

11.30

mmol/l

0.73

362

1542

(3018572) Chloride [Moles/volume] in Blood

401

1735

2.36

54.60

11.8

6.5

104.57

105.05

mmol/l

0.86

362

1543

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

4565

37738

1.38

52.77

2.9

2.6

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

176

498

3.58

52.41

1.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

2114

15263

1.49

52.16

4.5

3.7

225.25

514.50

ng/l

3.45

1633

11749

(3002030) Lymphocytes/100 leukocytes in Blood

4768

39785

1.37

51.59

7.3

6.4

27.07

28.18

8.81

4501

37347

(40761535) Cells panel - Urine sediment

1047

6449

1.69

51.25

3.8

3.5

—

(3010421) pH of Blood

450

2104

2.19

50.93

4.3

7.41

7.42

2.24

390

1911

(3018010) Neutrophils/100 leukocytes in Blood

4690

39172

1.37

49.73

7.0

6.2

57.49

56.93

2.23

4431

36749

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

784

4493

1.81

49.41

4.2

5.2

24.10

24.01

mmol/l

0.41

767

4410

(3019550) Sodium [Moles/volume] in Serum or Plasma

8829

82199

1.58

49.24

26.7

16.0

138.40

139.66

mmol/l

221.14

8692

80054

(3002582) Erythrocytes [#/volume] in Urine

3145

24654

1.40

49.07

3.7

3.3

60.39

95.99

e6/l

1.71

2540

18967

(3036180) Methadone [Presence] in Urine

157

433

3.67

48.59

1.7

2.9

—

(3030467) Casts [#/volume] in Urine by Automated count

2918

22617

1.41

48.52

3.6

3.2

0.41

e6/l

0.00

2345

17255

(3047181) Lactate [Moles/volume] in Blood

504

2509

2.06

48.44

10.7

5.5

1.49

1.31

mmol/l

1.96

445

2203

(3028271) Lactate [Moles/volume] in Capillary blood

311

1271

2.49

48.01

2.3

1.9

2.23

1.69

mmol/l

7.82

305

1245

(40758558) Short blood count panel - Blood

2680

20613

1.41

46.12

8.3

7.1

—

(3000850) Epithelial cells [#/volume] in Urine

2301

17228

1.43

46.09

2.9

2.6

6.01

5.39

e6/l

1.28

2125

15417

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

106

228

4.69

45.76

1.3

1.2

24.14

28.48

0.20

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

929

5724

1.68

45.16

1.9

1.7

—

(3012501) Base excess in Blood by calculation

390

1817

2.19

44.51

4.4

2.32

2.47

mmol/l

0.56

277

1203

(3013290) Carbon dioxide [Partial pressure] in Blood

390

1818

2.19

44.45

4.4

5.07

4.98

kpa

1.62

381

1777

(3027315) Oxygen [Partial pressure] in Blood

391

1828

2.18

44.23

4.4

8.64

8.71

kpa

0.39

382

1786

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

463

2311

2.05

44.14

1.3

—

(3018095) Leukocytes [#/volume] in Urine

3545

28710

1.36

44.02

4.3

3.8

96.63

91.81

e6/l

0.08

2692

20363

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1453

10027

1.52

43.78

2.2

1.8

1.71

1.44

20.23

1295

8809

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

12.33

43.48

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

2715

21110

1.39

43.29

5.0

4.0

0.00

estimate

2.60

828

7155

(36304419) Bacteria [Presence] in Urine

2818

22049

1.38

43.25

3.5

3.2

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.28

43.09

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

6285

55569

1.34

42.74

5.2

4.2

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

6098

53678

1.34

42.70

4.4

3.1

64.79

46.70

u/l

29.58

5779

50124

(1616796) Gas panel - Central venous blood

387

1828

2.16

42.66

3.8

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

562

3036

1.90

42.63

2.0

1.8

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

575

3136

1.88

42.35

2.5

1.9

2.70

2.27

ug/l

0.29

484

2758

(3023103) Potassium [Moles/volume] in Serum or Plasma

8801

82453

1.52

41.45

26.1

16.2

3.97

mmol/l

0.04

8649

80144

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

2641

20573

1.38

41.25

2.3

2.94

2.93

mg/l

0.06

2227

17624

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

168

539

3.15

41.04

1.2

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

211

770

2.78

40.95

1.6

1.8

—

(3028707) Methadone [Presence] in Urine by Screen method

339

1545

2.23

40.84

2.9

3.0

—

(40767503) Oxygen content in Capillary blood by calculation

363

1714

2.16

40.05

2.7

2.5

16.93

16.43

1.37

179

903

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

3836

31816

1.33

39.32

2.1

2.0

94.12

95.31

pmol/l

0.83

2130

16874

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

509

2740

1.90

38.99

3.5

4.0

0.36

0.34

u/ml

0.69

335

1555

(3015235) Bicarbonate [Moles/volume] in Capillary blood

418

2103

2.03

38.97

3.4

24.36

24.67

mmol/l

0.93

410

2056

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

474

2505

1.93

38.38

3.0

3.4

3.43

3.52

g/l

0.62

454

2386

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

6.39

38.26

1.5

1.1

48.83

57.85

0.56

(3019225) pH of Specimen

1129

7586

1.55

38.09

4.6

4.3

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

2398

18636

1.37

37.33

4.3

3.6

—

(3028626) Oxygen [Partial pressure] in Capillary blood

474

2534

1.91

37.07

5.3

5.0

8.80

8.67

kpa

0.64

462

2470

(3007853) Bacteria identified in Skin by Aerobe culture

1366

9708

1.47

35.00

1.9

1.8

—

(3015736) pH of Urine

3808

31930

1.31

34.78

4.1

3.3

6.15

5.88

3.42

165

2478

(3035350) Ketones [Presence] in Urine by Test strip

4588

39446

1.30

34.68

4.5

3.6

0.00

estimate

3.26

919

7874

(3022806) Fractional oxyhemoglobin in Capillary blood

241

1022

2.39

34.38

2.2

1.9

89.43

89.84

0.53

235

1010

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

143

467

3.09

33.97

1.0

277.28

316.05

ng/l

1.06

103

319

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

2241

17465

1.36

33.72

2.0

1.9

1.19

1.22

mg/l

0.13

1729

13239

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1293

9165

1.47

33.47

4.3

252.40

242.15

u/l

0.73

1218

8653

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

142

471

3.04

32.86

1.0

37.17

43.26

ng/l

1.17

319

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

626

3772

1.70

32.79

5.5

4.9

24.74

24.67

mmol/l

0.25

586

3516

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

141

468

3.04

32.59

1.0

747.27

735.86

ng/l

0.10

100

311

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1820

13826

1.38

31.87

3.1

2.8

1.20

1.12

e6/l

0.42

1076

7969

(3022313) Gas panel - Capillary blood

680

4219

1.65

31.86

5.1

4.7

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

130

422

3.11

31.23

1.1

1.05

1.07

u/l

0.13

190

(3009261) Glucose [Presence] in Urine by Test strip

4591

39809

1.28

31.18

4.5

3.6

0.00

estimate

2.20

842

7261

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

8625

81452

1.40

29.76

22.5

14.0

24.04

24.09

mg/l

0.06

7503

64275

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

419

7257

0.56

29.70

1.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

4529

39389

1.27

29.33

5.8

4.8

0.00

estimate

0.80

865

7467

(3042936) Bacteria identified in Isolate by Culture

1522

11387

1.40

28.92

2.2

2.0

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

6.37

28.53

1.1

—

(21494755) Public health laboratory ask at order entry panel

493

8080

0.59

28.35

1.3

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

552

3345

1.69

28.27

2.1

1.9

—

(3027945) Reticulocytes/100 erythrocytes in Blood

1267

9226

1.43

28.07

2.9

2.7

1.81

1.73

1.83

1114

8179

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

9.45

27.91

1.2

1.4

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

2103

16655

1.33

27.60

1.7

29858816.33

30484366.43

pmol/l

0.02

1765

13886

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

109

350

3.14

26.74

1.9

2.2

145.87

155.66

umol/l

0.11

189

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

2668

21918

1.29

26.64

3.1

3.2

1459.14

1529.03

ng/l

0.32

2311

18782

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

229

1065

2.18

26.34

6.0

6.8

10.72

11.48

mg/l

1.72

200

981

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

7.11

26.22

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

114

4.93

25.93

1.1

1.0

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

419

2419

1.76

25.55

3.5

3.2

185.60

187.31

0.15

399

2305

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

1673

12950

1.35

25.38

3.3

3.0

3.52

2.36

e6/l

3.74

940

7141

(3023520) Reticulocytes [#/volume] in Blood

970

6846

1.46

25.29

2.7

2.6

70.09

69.09

e9/l

0.36

727

5125

(3021901) Oxygen saturation in Capillary blood

291

1510

1.95

24.91

2.8

3.0

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

8.44

24.83

1.8

1.2

29.62

38.57

0.42

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

6661

61212

1.26

24.68

4.3

3.9

14.31

14.77

pmol/l

38.07

6115

55703

(3052851) Hemolysis interference index of Serum or Plasma

421

2459

1.74

24.65

3.4

3.2

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

117

4.72

24.20

1.1

1.0

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

174

748

2.35

24.19

2.6

3.0

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3539

30374

1.25

24.07

4.8

3.7

—

(3014271) Vancomycin [Susceptibility]

110

381

2.91

23.70

2.9

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

262

4867

0.53

23.45

1.4

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

19.50

23.37

1.1

1.0

—

(3021589) Normoblasts [#/volume] in Blood

4131

36191

1.24

23.01

11.4

9.6

0.00

e9/l

0.50

3365

29453

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

302

3.10

22.45

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

226

1113

2.05

22.45

1.5

1.6

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

7319

77565

0.79

22.16

4.3

4.2

1.46

1.44

mmol/l

3.78

6757

71796

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

319

1776

1.82

22.01

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

319

1776

1.82

22.01

1.4

1.3

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1029

7533

1.41

21.82

2.5

2.4

0.21

g/l

0.11

955

7010

(3024869) Neuronal Ab [Presence] in Serum

129

4.28

21.48

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

436

2687

1.65

20.93

2.8

3.3

94.75

91.78

1.76

420

2588

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

102

364

2.82

20.86

2.7

2.4

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

452

2815

1.63

20.81

2.7

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

865

6213

1.43

20.38

2.5

2.8

10.19

10.46

g/l

0.88

791

5692

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

7553

79543

0.80

19.97

4.8

4.7

2.67

2.75

mmol/l

9.98

6982

73592

(3020630) Protein [Mass/volume] in Serum or Plasma

887

6434

1.41

19.76

2.3

2.5

65.92

66.32

g/l

0.73

801

5854

(3028679) Herpes simplex virus Ab [Presence] in Serum

110

423

2.62

19.50

1.2

—

(3024928) Oxygen saturation in Venous blood

301

1713

1.78

19.34

3.7

4.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

7412

78141

0.81

19.21

4.4

4.3

4.58

4.62

mmol/l

2.99

6883

72711

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

5.55

19.08

1.2

1.1

11.83

20.06

—

(3016879) Cocaine [Presence] in Urine

514

3376

1.55

18.90

2.5

2.2

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3701

32538

1.22

18.63

2.4

2.3

73.67

76.33

nmol/l

6.72

3298

29398

(3040151) Glucose [Moles/volume] in Capillary blood

189

936

2.04

18.57

9.4

7.0

7.31

7.36

mmol/l

0.07

161

780

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

700

4952

1.44

17.88

1.3

37.55

54.15

au/ml

1.84

261

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

868

6406

1.39

17.42

4.1

3.9

1.21

1.23

mmol/l

7.85

809

5585

(40757494) Bilirubin.total [Moles/volume] in Blood

108

440

2.47

17.05

2.2

2.6

39.99

53.11

umol/l

0.27

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

750

5419

1.41

17.03

2.3

2.4

28.94

22.65

au/ml

0.61

413

(3000764) Benzodiazepines [Presence] in Urine

535

3629

1.50

16.93

2.5

2.1

—

(3028300) Cannabinoids [Presence] in Urine

538

3657

1.50

16.86

2.5

2.1

—

(3027008) Opiates [Presence] in Urine

537

3652

1.50

16.78

2.4

2.0

—

(3011288) Drugs identified in Urine by Screen method

381

2417

1.60

16.31

3.4

3.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

407

2623

1.57

16.30

2.5

2.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

265

1535

1.74

16.09

1.6

—

(3017569) Oxygen content in Arterial blood

358

2.58

16.01

1.7

2.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

374

2378

1.59

15.87

1.7

—

(3044242) Glucose [Moles/volume] in Arterial blood

372

2.54

15.81

1.8

2.0

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

217

1196

1.83

15.59

1.2

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

103

4.09

15.55

1.7

1.9

—

(3027944) Amphetamines [Presence] in Urine

522

3587

1.48

15.51

2.2

2.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1036

8037

1.32

14.94

4.2

3.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

1572

12869

1.26

14.92

2.6

2.5

12.69

13.10

umol/l

1.29

1441

12000

(3006184) Hemoglobin [Mass/volume] in Capillary blood

301

1852

1.64

14.63

2.2

132.73

129.93

g/l

1.30

249

1352

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

282

2.71

14.57

2.9

2.3

141.09

145.95

nmol/l

0.17

239

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

232

1333

1.76

14.53

1.6

1.7

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

232

1333

1.76

14.53

1.6

1.7

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

7131

74905

0.84

14.32

4.0

3.8

1.30

1.29

mmol/l

0.38

6567

68817

(3013512) EKG study

2562

22206

1.21

13.99

4.5

3.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

305

1906

1.62

13.95

1.7

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

176

942

1.88

13.92

1.5

1.6

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

176

942

1.88

13.92

1.5

1.6

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1451

11867

1.26

13.80

2.6

2.5

2.30

2.34

g/l

1.73

1335

10983

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

520

3653

1.45

13.80

1.9

1.7

1.47

1.52

g/l

0.48

426

3141

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

309

1952

1.60

13.53

1.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

235

1390

1.71

13.31

1.5

—

(4034850) Laboratory test

380

2536

1.52

13.06

12.1

9.8

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

377

2.37

13.01

1.1

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

113

3.64

12.96

1.0

2.3

—

(40757373) Influenza virus identified in Isolate

157

3.19

12.93

1.5

—

(3013707) Erythrocyte sedimentation rate by Westergren method

6305

59173

1.17

12.85

4.2

4.0

12.46

11.79

mm/h

2.74

5894

54755

(3004588) Protein electrophoresis panel - Serum or Plasma

696

5211

1.36

12.73

2.1

2.3

—

(3011985) Renin [Units/volume] in Plasma

186

1043

1.80

12.71

1.5

64.06

67.36

mu/l

0.09

170

924

(3011412) CD3 cells [#/volume] in Blood

162

875

1.86

12.51

2.4

2.7

1.11

1.21

e9/l

0.57

143

768

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

209

1226

1.72

12.24

1.4

1.3

3.63

4.35

u/ml

0.53

543

(3017181) Myelocytes/100 leukocytes in Blood

870

6778

1.31

12.11

4.3

4.2

1.18

0.94

1.98

392

2284

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1350

11111

1.25

12.04

2.6

22.52

22.58

0.05

1109

9514

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

264

2.58

12.00

1.4

1.5

13.33

15.45

pmol/l

1.54

216

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

272

1738

1.58

11.41

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

8711

84356

1.23

11.39

20.9

13.0

—

(3004809) Band form neutrophils/100 leukocytes in Blood

219

1330

1.66

11.30

3.0

3.5

1.54

1.47

0.09

198

1170

(3001019) Free T4 and TSH panel - Serum or Plasma

264

4043

0.64

11.22

1.6

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

281

1817

1.56

11.20

1.5

1.7

—

(3028433) Virus identified in Specimen by Culture

298

2.42

11.14

1.2

—

(3051651) Icteric interference index of Serum or Plasma

105

509

2.07

11.12

2.7

4.1

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

159

887

1.80

11.12

3.4

4.2

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

564

4179

1.37

11.03

3.0

2.8

0.36

0.27

e6/l

0.47

552

4073

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

940

7493

1.28

10.96

2.6

2.5

41.71

44.10

u/l

0.11

806

6406

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

634

4790

1.34

10.94

2.8

3.3

4.30

4.50

pmol/l

5.01

569

4234

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

1310

15670

0.81

10.93

2.7

3.0

0.74

0.77

ug/l

0.31

916

10353

(3044889) 12 lead EKG panel

5824

54686

1.15

10.67

4.1

3.7

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

125

3.21

10.49

1.1

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

148

825

1.80

10.41

2.7

2.9

19.96

20.33

nmol/l

0.15

135

792

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

7674

73604

1.17

10.40

5.3

4.6

2.00

2.15

mu/l

0.41

7134

67576

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

358

2491

1.45

10.07

2.1

1.7

1.17

1.18

g/l

0.05

339

2366

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

123

655

1.89

10.02

1.5

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

123

655

1.89

10.02

1.5

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

123

655

1.89

10.02

1.5

1.7

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

348

2420

1.45

9.83

2.2

1.7

0.22

0.23

g/l

0.86

330

2296

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

223

1411

1.59

9.82

1.8

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

3.77

9.73

1.0

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

168

993

1.70

9.67

1.2

1.4

879.34

346.73

pmol/l

0.44

147

851

(3002179) Metamyelocytes/100 leukocytes in Blood

782

6192

1.28

9.61

4.1

4.0

0.84

0.69

1.17

340

1992

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

372

2.16

9.50

1.2

1.1

1668.97

1541.37

miu/ml

0.43

372

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

117

629

1.87

9.29

2.5

2.9

0.22

0.21

e9/l

0.09

533

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

120

651

1.85

9.26

2.4

2.8

481.69

501.17

e6/l

0.17

538

(3019977) pH of Arterial blood

429

2.06

9.26

3.0

2.6

7.42

7.43

0.52

150

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

9.48

9.24

1.1

—

(3052592) Norovirus Ag [Presence] in Stool

153

2.82

9.07

1.9

1.3

—

(3023419) Bacteria identified in Sputum by Culture

181

1114

1.64

8.96

2.4

2.7

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

200

1262

1.60

8.95

1.4

1.2

5.79

3.57

u/ml

0.72

412

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

100

519

1.93

8.85

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

3.50

8.76

1.0

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

429

3170

1.37

8.60

2.4

2.3

5995.26

5412.58

u/l

0.14

127

1242

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.24

8.58

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

471

1.96

8.49

2.9

2.6

43.61

39.72

1.20

261

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

508

1.92

8.39

1.4

—

(3035285) Chloride [Moles/volume] in Venous blood

159

964

1.66

8.38

3.4

2.3

104.35

105.59

mmol/l

2.16

159

953

(3037121) Protein [Mass/volume] in Urine

392

2868

1.38

8.37

3.5

3.6

0.25

0.34

g/l

1.99

210

1343

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

125

710

1.77

8.35

2.3

2.4

14.16

14.67

0.20

120

693

(3041354) Potassium [Moles/volume] in Venous blood

159

966

1.66

8.32

3.4

2.3

4.04

4.07

mmol/l

0.38

159

955

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

316

2231

1.43

8.29

1.2

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

120

676

1.78

8.25

2.5

2.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

132

766

1.73

8.19

1.1

—

(3032352) Blasts [#/volume] in Cerebral spinal fluid

3.20

8.18

2.0

4.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

2.37

8.11

3.7

2.6

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

228

2.37

8.11

3.7

2.6

—

(3021440) Promyelocytes/100 leukocytes in Blood

797

6457

1.25

8.11

4.5

4.2

0.17

0.11

0.95

324

1970

(3033705) Calcium.ionized [Moles/volume] in Venous blood

155

943

1.65

8.08

3.5

2.3

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

252

1713

1.48

8.08

5.1

6.1

328.32

2102.70

iu/ml

1.03

251

(3051611) Lipemic interference index of Serum or Plasma

141

838

1.69

8.03

2.9

3.5

—

(1175426) CD3 cells/100 lymphocytes in Blood

126

726

1.74

8.03

2.3

2.4

74.29

70.86

1.78

120

695

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1102

9262

1.21

7.92

3.1

6.40

8.11

umol/l

4.59

923

8035

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

10.78

7.78

1.2

1.0

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

179

1141

1.58

7.74

1.7

1.6

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

774

6286

1.25

7.71

3.3

2.6

71.13

66.91

ml/min/173m2

1.75

328

2505

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

378

2.02

7.65

4.5

1.9

153.15

142.29

0.53

359

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

4.50

7.63

2.4

5.0

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

134

798

1.69

7.60

2.7

3.6

58.60

56.20

0.63

113

671

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

179

1147

1.57

7.57

1.4

1.3

22.08

25.13

u/l

0.74

150

956

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

706

8686

0.80

7.52

1.4

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

202

1332

1.53

7.52

2.9

3.9

391.91

1585.42

u/ml

1.20

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

3.48

7.51

1.0

1.5

11.12

14.30

pmol/l

0.37

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

738

5990

1.25

7.40

4.0

4.2

81.47

90.00

ng/l

1.96

633

5221

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

163

1029

1.59

7.36

1.4

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

277

3864

0.71

7.32

1.4

1.5

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

184

1199

1.54

7.25

1.4

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

8788

85803

1.18

7.13

14.2

10.1

27.10

26.67

u/l

0.36

8572

82723

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

139

851

1.64

7.13

2.5

2.3

—

(3017509) Phencyclidine [Presence] in Urine

3.12

7.11

1.6

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

230

1579

1.47

7.07

1.3

1.4

—

(3000494) Fungus identified in Specimen by Culture

1089

9241

1.20

7.06

1.5

—

(3049233) Organic acids panel - Urine

6.01

7.05

1.4

1.1

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

13.76

6.88

1.1

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

173

2.43

6.72

1.1

1.2

75.29

72.08

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

396

3007

1.33

6.71

1.8

1.6

359.26

298.28

mu/l

2.56

359

2716

(3009445) Proteinase 3 Ab [Units/volume] in Serum

448

3462

1.31

6.70

1.5

1.6

27.21

14.66

u/ml

0.55

104

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

3.14

6.69

2.4

2.0

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

150

955

1.58

6.59

1.3

—

(3025159) Blasts/100 leukocytes in Blood

746

6147

1.23

6.53

4.5

4.2

0.24

0.35

0.23

273

1679

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

808

6713

1.22

6.53

3.0

168.65

211.02

ng/l

3.13

735

6073

(3011648) Oxygen content in Venous blood

112

665

1.69

6.50

4.8

4.3

11.24

11.26

0.01

112

665

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

164

2.44

6.48

1.3

1.7

—

(3034552) Adenosine deaminase [Enzymatic activity/volume] in Cerebral spinal fluid

3.92

6.42

1.1

1.57

5.20

u/l

—

(40768804) Tissue Pathology biopsy report

3420

31701

1.12

6.35

2.2

2.1

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

167

1099

1.53

6.35

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

172

2.39

6.33

1.0

1.2

63.57

78.98

—

(3012787) Ethosuximide [Moles/volume] in Serum or Plasma

+∞

6.25

5.2

0.0

326.00

—

umol/l

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

562

1.73

6.17

1.1

1.3

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

299

2.01

6.10

4.4

1.9

167.20

0.00

282

(3037756) Immunofixation for Serum or Plasma

227

1602

1.43

6.09

1.4

1.6

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

174

1172

1.49

5.95

1.2

1.1

119.31

115.19

0.89

154

1054

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

257

2.07

5.81

1.1

80.50

88.30

0.53

128

(3042517) Benzodiazepines panel - Urine

2.82

5.81

3.7

2.6

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

476

1.77

5.79

12.9

11.8

0.62

0.61

mmol/l

0.09

439

(40768800) Prostate Pathology biopsy report

103

1667

0.61

5.78

1.1

1.2

—

(3028717) Thiamine [Mass/volume] in Blood

2.91

5.71

1.1

1.2

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

160

1070

1.50

5.69

1.3

0.18

0.26

nmol/l

0.67

(3039443) Prostate specific Ag panel - Serum or Plasma

1523

0.60

5.67

1.5

1.6

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

2.80

5.54

2.3

1.9

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

311

1.93

5.50

2.7

2.5

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

162

1095

1.49

5.49

1.5

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

180

2565

0.70

5.48

1.6

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

136

2027

0.67

5.27

1.3

1.4

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

150

2193

0.68

5.26

1.4

1.5

—

(3028026) IgM [Mass/volume] in Serum or Plasma

589

4850

1.23

5.24

1.8

1.9

1.19

1.32

g/l

1.50

533

4433

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

169

2.25

5.20

2.7

2.2

1.50

1.71

mmol/l

0.14

120

(3003434) Protein [Mass/volume] in Pleural fluid

156

1059

1.48

5.19

1.4

1.5

34.14

32.27

g/l

1.10

149

955

(3024891) Influenza virus A+B Ag [Presence] in Specimen

298

2260

1.33

5.19

1.2

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

136

2020

0.67

5.18

1.3

1.4

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3781

35517

1.10

5.16

3.0

2.9

139.20

126.20

ug/l

1.38

3473

32933

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

136

2017

0.67

5.15

1.3

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

137

2025

0.67

5.10

1.3

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

252

1.99

5.00

1.1

1.2

71.08

87.38

1.11

128

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

353

2757

1.29

4.97

1.6

473.85

343.29

titre

0.20

111

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

402

1.77

4.97

2.6

27.55

27.66

0.02

386

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

361

1.80

4.86

3.3

3.5

—

(3006245) CD3-CD19+ cells/100 cells in Blood

420

1.74

4.85

2.6

2.9

11.20

12.79

0.35

399

(3009214) Lutropin [Units/volume] in Serum or Plasma

342

2672

1.29

4.82

1.5

10.23

9.06

u/l

0.82

279

2114

(3000492) Spirometry study

671

7926

0.84

4.79

1.5

1.4

—

(3002079) Sodium [Moles/time] in 24 hour Urine

349

1.81

4.76

1.2

1.3

161.83

165.56

mmol/24h

0.11

349

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

217

2918

0.74

4.69

1.5

1.7

6.11

3.92

mg/l

0.99

168

2107

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

447

1.70

4.68

1.3

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

148

1017

1.46

4.68

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

145

995

1.46

4.62

1.4

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

308

2389

1.30

4.60

2.5

3.3

31.07

51.94

mg/l

2.66

267

1942

(3034860) Kappa light chains.free [Mass/volume] in Serum

308

2391

1.30

4.58

2.5

3.3

47.68

81.96

mg/l

0.78

266

1943

(3023199) Leukocytes [#/volume] in Pleural fluid

138

944

1.47

4.48

1.4

1.5

2427.09

2321.90

e6/l

0.09

114

682

(3017732) Neutrophils [#/volume] in Blood

659

5575

1.19

4.47

3.6

2.8

4.43

4.94

e9/l

0.95

518

4523

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

295

2286

1.30

4.46

1.2

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1857

20307

0.89

4.45

1.6

1.36

1.37

mmol/l

0.29

1611

17162

(3025468) Yersinia sp identified in Specimen by Organism specific culture

144

995

1.45

4.45

1.4

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

109

1635

0.66

4.43

1.4

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

297

2306

1.30

4.42

1.2

—

(42529406) Shigella sp [Presence] in Stool by Culture

298

2317

1.29

4.39

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

379

3038

1.26

4.37

1.2

0.50

1.07

u/ml

1.32

280

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

129

876

1.48

4.36

1.2

1.1

92.21

96.02

0.95

117

818

(3005033) Fetal Nuchal fold Thickness US

109

1627

0.67

4.33

1.4

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

144

1001

1.44

4.32

1.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

114

1680

0.67

4.25

1.4

1.5

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

145

2.21

4.25

1.2

0.85

120.21

mg/l

1.44

113

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

307

2409

1.28

4.23

2.0

1.8

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

298

2331

1.29

4.21

2.5

3.2

17.28

3.47

ratio

0.41

185

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

143

998

1.44

4.21

1.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

208

1547

1.35

4.21

1.5

1.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

578

1.58

4.20

1.4

1.5

12.74

12.75

u/l

0.01

557

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

126

859

1.47

4.19

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

143

1001

1.43

4.15

1.4

—

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

389

1.70

4.09

1.1

26.14

15.84

u/ml

—

(3013336) Amino acids [Identifier] in Serum or Plasma

3.08

4.07

3.9

2.9

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

284

2220

1.29

4.05

1.4

1.5

15.43

13.77

iu/ml

—

(4200892) Spirometry reversibility

648

5526

1.18

4.04

1.5

1.4

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

759

8744

0.86

4.04

1.6

1.7

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

245

1.88

3.99

2.3

3.2

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

205

1.95

3.89

1.4

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

511

1.59

3.87

1.5

1.4

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

123

850

1.45

3.85

1.4

1.5

81780.90

56537.25

e6/l

0.40

502

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

381

1.68

3.85

1.4

1.5

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

381

1.68

3.85

1.4

1.5

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

412

1.65

3.83

2.2

1.7

1.21

3.06

u/field

2.20

288

(3006922) Hepatitis E virus Ab [Presence] in Serum

553

1.56

3.80

1.1

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

169

1240

1.37

3.77

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

8.75

3.77

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

258

1.82

3.74

2.1

2.0

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

188

1.97

3.70

1.1

1.2

349.79

284.41

pmol/l

0.43

132

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

203

1.92

3.65

1.4

1.3

118.56

132.67

nmol/l

0.21

152

(3022621) pH of Urine by Test strip

609

5215

1.18

3.64

3.6

2.9

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

110

2.27

3.60

1.2

1.1

—

(3003694) ABO and Rh group [Type] in Blood

2465

23012

1.09

3.59

1.4

1.5

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

351

1.68

3.58

1.7

1.6

1642666.67

1712040.29

iu/ml

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1117

12423

0.89

3.56

1.3

1.2

18.09

11.29

u/ml

0.58

429

4822

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

117

2.22

3.56

1.2

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

322

1.71

3.54

2.0

2.1

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

342

2782

1.24

3.53

2.1

2.3

3.00

2.96

g/l

0.32

292

2503

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

140

1008

1.39

3.53

1.7

1.6

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

228

1.84

3.48

1.1

1.2

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

566

1.52

3.46

1.2

1.3

11.49

12.64

u/l

0.43

519

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

173

1298

1.34

3.39

1.1

1.2

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

153

2.03

3.38

1.2

1.1

0.81

0.70

umol/24h

0.55

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

168

1256

1.34

3.37

1.2

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

362

2980

1.22

3.35

2.1

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

362

2981

1.22

3.34

2.1

2.2

7.29

7.42

g/l

0.72

312

2697

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

127

2.13

3.34

1.0

1.4

39.93

112.57

ng/l

1.53

(3020911) Cortisol [Moles/time] in 24 hour Urine

268

1.76

3.34

1.3

131.53

186.12

nmol/24h

0.41

268

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

2023

21737

0.91

3.34

4.0

4.2

21.42

22.01

0.96

966

10493

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1969

18250

1.10

3.33

1.3

1.49

1.91

u/ml

0.97

525

4799

(3001964) Herpes simplex virus Ag [Presence] in Specimen

239

1.80

3.32

1.5

1.6

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

3.93

3.28

1.4

1.3

608.74

476.03

nmol/l

0.23

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

131

947

1.39

3.26

1.9

2.1

46.17

23.42

mg/l

1.98

241

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

360

2976

1.22

3.22

2.1

2.2

3.58

3.69

g/l

0.73

311

2696

(3026250) Tacrolimus [Mass/volume] in Blood

401

1.60

3.21

32.9

36.8

6.93

7.20

ug/l

0.48

370

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

370

1.62

3.21

1.4

1.6

2.14

5.41

nmol/l

1.51

296

(3045788) Cell count panel - Pleural fluid

105

732

1.44

3.21

1.4

1.5

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

4.17

3.19

1.1

1.0

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1752

16187

1.10

3.17

1.5

2.34

2.37

g/l

0.21

1054

9767

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.35

3.14

3.2

2.4

0.65

0.56

u/field

0.15

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

286

2317

1.24

3.11

1.4

1.5

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

421

1.57

3.09

1.1

1.2

333.40

322.63

u/l

0.03

384

(4094501) Cardiovascular stress test using bicycle ergometer

156

2057

0.75

3.08

1.1

—

(3000060) B lymphocytes [#/volume] in Blood

328

1.65

3.08

2.5

2.9

921.20

485.59

e6/l

0.24

195

(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid

5.83

3.02

1.0

1.1

3.04

1.11

mg/l

—

(3026389) Candida sp identified in Specimen by Organism specific culture

150

1127

1.34

2.96

1.4

1.3

—

(3012441) Differential panel - Pleural fluid

115

829

1.39

2.95

1.4

1.5

—

(3045424) Erythrocytes [Presence] in Urine

170

1302

1.31

2.94

1.5

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1329

0.70

2.92

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

7063

72141

0.93

2.92

5.7

5.6

39.21

39.66

mmol/mol

3.40

6542

66890

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

2.32

2.90

8.1

9.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

142

1877

0.75

2.88

1.5

1.6

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

2574

27226

0.93

2.87

4.3

4.9

3.05

3.26

ug/l

0.21

2289

24432

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

129

953

1.36

2.86

1.1

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

178

1.86

2.85

1.6

1.4

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

158

1204

1.32

2.84

1.3

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

3.16

2.84

1.0

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

519

0.54

2.81

1.1

0.98

2.04

u/ml

—

175

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

172

1.86

2.79

2.8

2.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

273

2237

1.23

2.72

1.3

116.92

149.31

titre

0.23

188

(3010838) Calcium [Moles/time] in 24 hour Urine

170

1318

1.29

2.71

1.7

1.9

4.57

4.95

mmol/24h

0.96

151

1155

(40760888) Immunoglobulin light chains.free panel - Serum

226

1815

1.25

2.71

2.7

3.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

113

827

1.37

2.68

1.2

—

33.60

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

331

2770

1.20

2.67

2.1

2.2

10.16

10.22

g/l

0.08

280

2468

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

113

828

1.37

2.66

1.1

—

(40768806) Pleura Pathology biopsy report

113

828

1.37

2.66

1.4

1.6

—

(3044009) aPTT.lupus sensitive (LA screen)

2.33

2.64

1.1

1.2

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

2.15

2.60

3.6

3.5

9.54

3.74

0.76

(3042111) Morphology [Interpretation] in Bone marrow Narrative

168

1310

1.29

2.58

1.7

1.6

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1214

13203

0.91

2.58

1.3

28.54

33.04

iu/ml

0.49

340

4085

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

303

2525

1.21

2.57

2.0

2.3

0.69

0.91

g/l

0.52

246

2175

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

604

5321

1.14

2.57

1.2

90.06

144.78

iu/ml

3.90

228

1967

(3013931) Oligosaccharides [Presence] in Urine

7.14

2.55

1.0

—

(3019174) dRVVT (LA screen)

2.27

2.50

1.1

1.2

—

(3034770) Mitochondria Ab [Titer] in Serum

269

2223

1.22

2.49

1.3

653.33

980.30

titre

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

285

1.62

2.49

1.2

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

340

1.56

2.49

1.2

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

3.46

2.47

1.1

4.2

—

(3002385) Erythrocyte distribution width [Ratio]

7190

70435

1.07

2.47

25.8

16.7

14.86

0.00

7110

69146

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

217

1.71

2.47

1.3

16.61

270.29

ug/l

1.32

112

(3019897) Erythrocyte distribution width [Ratio] by Automated count

1053

0.70

2.45

3.7

2.6

13.40

13.13

1.25

1040

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

629

1.40

2.43

2.2

2.0

2.30

1.71

u/field

0.42

246

(3014599) Egg white IgE Ab [Units/volume] in Serum

594

0.60

2.41

1.2

1.35

8.06

u/ml

—

206

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

116

869

1.34

2.41

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

206

1663

1.24

2.40

1.5

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.17

2.40

1.5

1.3

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

515

1.44

2.38

1.1

—

(3003593) Leptospira sp IgG Ab [Units/volume] in Serum

6.25

2.37

1.2

1.3

—

(3001409) Leptospira sp IgM Ab [Units/volume] in Serum

6.25

2.37

1.2

1.3

—

(3008898) HLA-B27 [Presence]

231

2804

0.82

2.36

1.1

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.12

2.35

2.3

2.0

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1075

9849

1.10

2.34

1.7

1.6

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

517

1.43

2.33

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

280

2341

1.20

2.33

1.4

1.3

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

383

3290

1.17

2.33

1.8

1.9

39.71

39.05

u/l

0.23

345

2915

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

536

1.42

2.29

1.2

1.1

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

268

2236

1.20

2.28

1.9

2.2

0.03

0.04

g/l

0.17

232

2049

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

112

1474

0.76

2.28

1.4

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

421

0.54

2.28

1.2

1.4

27.07

31.99

nmol/l

0.40

373

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

308

1.56

2.28

3.1

2.6

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

4.61

2.27

1.0

1.2

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

674

1.37

2.23

1.2

1.3

196.47

198.90

titre

0.01

136

(3002256) Pathology report gross observation

939

10263

0.91

2.23

1.2

1.3

—

(3004451) EKG impression Narrative

383

1.49

2.21

1.3

—

(3037522) Nuclear Ab [Titer] in Serum

1174

10834

1.09

2.20

1.4

507.85

533.64

titre

0.20

247

2167

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

121

926

1.31

2.20

2.5

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

202

1.68

2.19

1.2

1.1

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

249

2073

1.21

2.19

2.0

2.2

0.01

0.00

g/l

0.45

213

1894

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

125

964

1.30

2.15

2.0

1.6

—

(3016135) IgD [Mass/volume] in Serum

3.68

2.15

1.0

1.1

22.14

59.88

mg/l

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

2.62

2.13

1.5

1.7

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

274

2308

1.19

2.13

1.9

2.1

36.93

37.66

g/l

1.01

224

2022

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

167

1.74

2.10

1.2

1.3

—

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

228

1.62

2.10

1.4

2.0

32.23

42.36

u/l

0.30

208

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

2.26

2.07

1.2

1.0

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

246

2059

1.20

2.06

1.9

1.8

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

465

1.42

2.03

1.0

1.1

0.12

9.97

nmol/l

—

101

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

192

1.67

2.02

1.2

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

104

1.92

1.99

1.7

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

243

2042

1.19

1.97

2.0

2.2

0.00

g/l

-0.00

213

1888

(3022145) Colonoscopy Study observation

801

8763

0.91

1.96

1.3

1.4

—

(3032641) Amino acids panel - Urine

3.33

1.96

1.1

1.2

—

(3026692) Albumin [Mass/volume] in Peritoneal fluid

186

1.67

1.96

1.3

1.6

11.38

13.62

g/l

0.59

147

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

153

1895

0.80

1.96

1.2

1.1

1.80

2.48

u/ml

0.55

1035

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

315

1.49

1.89

1.0

1.3

—

(3020874) Milk IgE Ab [Units/volume] in Serum

592

0.66

1.89

1.1

1.2

0.59

3.00

u/ml

2.11

246

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

2.65

1.86

1.0

1.5

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

292

1.51

1.86

1.2

1.1

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

399

1.43

1.85

1.8

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

399

1.43

1.85

1.8

2.0

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

192

1589

1.21

1.85

1.8

1.7

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

137

1704

0.80

1.84

1.8

—

(3012920) Ethanol [Mass/volume] in Serum or Plasma

3.53

1.83

1.3

1.4

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

3.53

1.83

1.7

1.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

1189

0.76

1.83

1.1

2.50

3.53

u/ml

0.76

542

(3042631) Mycobacterium sp identified in Specimen

131

1042

1.26

1.82

2.5

2.9

—

(3030313) Adrenal Ab [Titer] in Serum

2.00

1.79

1.7

1.2

—

(3034426) Prothrombin time (PT)

287

1.50

1.78

1.3

1.2

—

(3035880) pH of Pleural fluid

436

1.40

1.77

1.2

1.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

464

4131

1.13

1.77

2.5

2.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

729

1.31

1.76

1.3

1.5

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

2.09

1.75

1.0

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

455

1.39

1.73

1.6

2.8

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

127

1580

0.80

1.73

1.1

3.68

2.19

u/ml

0.44

876

(3000570) Elastase.pancreatic [Mass/mass] in Stool

269

2311

1.17

1.72

1.4

260.45

277.70

ug/g

0.72

158

1349

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

397

0.60

1.72

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

306

1.47

1.71

2.0

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

306

1.47

1.71

2.0

2.2

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

543

1.35

1.69

1.8

1.6

72.22

83.27

umol/l

3.61

543

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

847

7810

1.09

1.67

4.0

4.1

13.52

30.42

ug/l

1.93

690

6336

(3012494) Peanut IgE Ab [Units/volume] in Serum

318

0.56

1.66

1.0

1.2

7.94

14.81

u/ml

—

201

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

284

1.48

1.65

1.1

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

309

1.46

1.64

2.0

2.2

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

161

1328

1.22

1.64

1.2

1.1

7238.22

7338.65

iu/ml

0.00

337

(3014133) Dog dander IgE Ab [Units/volume] in Serum

100

1269

0.79

1.64

1.1

3.49

4.13

u/ml

0.14

633

(3020491) Glucose [Moles/volume] in Blood

624

1.32

1.63

1.8

2.0

7.76

6.52

mmol/l

2.06

453

(1761482) Bacteria [#/volume] in Urine by Culture

236

2019

1.17

1.61

5.2

4.1

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

287

2493

1.15

1.61

5.8

6.1

1.50

1.44

mg/l

0.52

262

2311

(1617658) Protocol used for examination of sentinel lymph nodes

510

0.67

1.60

1.0

1.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

270

1.48

1.60

1.2

1.1

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

353

1.42

1.59

1.1

93.05

93.39

0.02

278

(3019420) Tryptase [Mass/volume] in Serum or Plasma

430

1.37

1.57

1.4

1.5

5.97

7.64

ug/l

1.30

381

(46235355) HIV 1 and 2 tests - Meaningful Use set

1667

15808

1.06

1.56

1.9

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

305

1.44

1.55

1.2

1.1

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

176

1.59

1.53

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

7536

76304

0.95

1.52

4.6

4.4

5.88

5.92

mmol/l

1.71

6892

69673

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

2.86

1.50

1.0

1.3

—

mmol/l

—

(3032057) Clostridioides difficile [Presence] in Stool

170

1.59

1.48

1.4

1.9

—

(3041096) Erythrocytes [Presence] in Urine by Automated

2241

21475

1.06

1.47

4.1

3.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

167

0.48

1.46

1.1

11.29

56.80

u/ml

—

160

(40768793) Breast Pathology biopsy report

127

1545

0.82

1.45

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

132

1.67

1.45

1.5

1.7

107.15

136.99

ng/l

0.59

132

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

523

1.32

1.45

3.0

3.3

143.45

142.99

nmol/l

0.00

518

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.12

1.44

2.3

1.3

—

(3026820) Hemoglobin [Mass/volume] in Venous cord blood

3.12

1.43

1.0

183.20

158.69

g/l

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

302

1.42

1.43

1.1

1.2

—

(40761536) Microorganisms panel - Urine sediment

746

6896

1.09

1.42

4.6

3.8

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.79

1.42

1.1

1.0

0.01

0.60

u/ml

—

(36660697) Celiac disease serology panel - Serum

721

6656

1.09

1.42

1.2

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

382

3418

1.12

1.40

1.1

1.15

9.64

u/ml

0.66

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

1072

0.79

1.37

1.2

1.4

2.79

4.50

ug/l

2.52

965

(3008401) Mugwort IgE Ab [Units/volume] in Serum

138

1653

0.83

1.36

1.1

0.54

1.25

u/ml

2.85

800

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

2.19

1.36

1.0

1.1

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

158

1.58

1.36

1.3

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

158

1.58

1.36

1.3

1.2

—

(37021550) Renin [Units/volume] in Plasma --upright

182

1.54

1.36

1.3

1.4

144.19

107.38

mu/l

0.22

141

(3045414) Leukocytes [Presence] in Urine

396

3559

1.12

1.36

1.9

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

143

1705

0.84

1.35

1.1

4.46

6.23

u/ml

0.95

958

(3035320) C reactive protein [Mass/volume] in Body fluid

591

1.29

1.35

2.6

2.3

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

583

0.72

1.34

1.0

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

167

1.56

1.33

1.7

1.6

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

1134

0.80

1.33

1.3

6.98

7.22

mmol/l

0.30

1005

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

606

5571

1.09

1.33

1.9

2.0

—

(3025941) Bacteria identified in Stool by Culture

508

4633

1.10

1.32

1.3

1.2

—

(3044927) Protein electrophoresis panel - Urine

762

1.25

1.32

1.5

1.1

—

(3020682) Albumin/Creatinine [Ratio] in Urine

2289

23761

0.95

1.31

3.8

3.9

12.08

9.86

mg/mmol

1.04

1500

15335

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

242

1.45

1.29

1.1

1.2

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

429

1.33

1.28

1.6

1.5

1.10

1.24

nmol/l

0.68

329

(3010144) Erythrocytes [#/volume] in Synovial fluid

711

1.25

1.28

1.5

1.3

128502.37

118078.32

e6/l

0.06

485

(3004347) Hepatitis D virus Ab [Presence] in Serum

2.78

1.28

1.0

—

(3036782) Glucose [Moles/volume] in Pleural fluid

738

1.25

1.28

1.3

1.4

6.11

6.39

mmol/l

0.59

678

(3004446) Plasmodium sp identified in Blood by Light microscopy

1.88

1.28

2.2

2.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

1.88

1.28

1.2

2.34

1.71

umol/24h

0.63

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

596

1.28

1.9

1.8

—

(3017704) Immunofixation for Urine

421

1.33

1.27

1.5

—

(3000963) Hemoglobin [Mass/volume] in Blood

9019

90752

0.94

1.24

33.0

20.5

132.73

135.81

g/l

73.91

8920

89455

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1499

15711

0.95

1.24

1.6

—

(3042951) Complement C1q Ab [Units/volume] in Serum

2.22

1.24

1.0

1.1

—

23.61

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.22

1.24

1.0

1.2

219.38

305.17

nmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

1187

0.81

1.22

1.1

6.46

5.40

u/ml

0.15

520

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

142

1198

1.19

1.22

1.4

0.33

0.40

nmol/l

0.65

112

943

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1082

11438

0.94

1.20

1.4

1.5

—

(3026361) Erythrocytes [#/volume] in Blood

9018

90728

0.94

1.20

32.7

20.4

4.39

4.52

e12/l

107.23

8835

88063

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

695

0.76

1.20

1.2

1.3

199.91

184.29

pmol/l

0.16

695

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

263

1.41

1.19

1.2

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

576

1.27

1.19

1.7

1.6

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

289

1.38

1.18

1.3

1.2

—

(3035941) MCH [Entitic mass]

9017

90711

0.94

1.18

32.5

20.3

30.49

30.24

32.30

8917

89412

(3020961) Endomysium IgA Ab [Titer] in Serum

445

4062

1.10

1.17

1.2

1.1

125.50

190.48

titre

—

116

(3022493) Free Hemoglobin [Mass/volume] in Plasma

367

1.34

1.16

7.1

5.3

75.95

693.04

mg/l

0.49

267

(3024731) MCV [Entitic volume]

9018

90716

0.94

1.16

32.6

20.3

91.06

90.68

11.77

8919

89414

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.50

1.15

1.0

2.1

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

171

1474

1.16

1.15

3.6

3.1

0.73

0.83

nmol/l

3.73

131

1112

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

1.81

1.14

1.3

1.4

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

158

1.52

1.14

1.3

1.2

—

(3029075) Extractable nuclear Ab panel - Serum

247

0.61

1.14

1.0

1.1

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

355

0.67

1.13

1.9

1.5

5.33

3.91

—

(3010813) Leukocytes [#/volume] in Blood

9021

90734

0.94

1.13

32.7

20.4

6.82

6.77

e9/l

0.95

8843

88033

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

1054

0.81

1.12

1.1

0.07

0.64

u/ml

2.42

338

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

413

1.31

1.12

1.3

1.9

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

413

1.31

1.12

1.3

1.9

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

572

1.26

1.12

2.1

1.6

29.89

23.46

u/ml

0.56

127

(21494434) Karyotype in Bone marrow

680

1.24

1.11

1.3

1.2

—

(1002224) Polysomnography panel

292

3251

0.89

1.11

1.1

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

111

1.62

1.11

1.1

1.2

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

816

1.21

1.11

1.2

66.99

70.28

u/l

0.13

731

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.70

1.10

1.1

1.0

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

220

0.59

1.10

1.5

1.8

—

148.73

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

268

1.38

1.09

1.9

2.2

634.80

3578.06

e6/l

0.52

188

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

637

1.24

1.09

1.9

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

226

1.42

1.09

1.4

1.3

56.97

55.86

0.06

188

(3041918) Cholesterol [Moles/volume] in Pleural fluid

152

1.51

1.08

1.1

1.2

1.71

1.63

mmol/l

0.14

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

2.19

1.08

1.0

1.5

40.74

21.73

nmol/l

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

7538

74532

1.04

1.07

19.2

13.0

87.10

82.28

ml/min/173m2

58.55

6414

61406

(3004616) Nuclear Ab [Presence] in Serum

110

920

1.20

1.07

1.4

1.3

—

(3010375) cycloSPORINE [Mass/volume] in Blood

434

1.29

1.07

25.0

26.6

106.87

118.76

ug/l

0.78

362

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

237

2103

1.13

1.07

1.9

11.50

11.31

mg/l

0.12

215

1963

(3001186) Copper [Moles/volume] in Serum or Plasma

202

1.44

1.06

1.1

1.3

16.33

16.76

umol/l

0.18

181

(3037692) Legionella sp identified in Specimen by Organism specific culture

261

1.38

1.06

1.4

1.5

—

(3000012) Reticulocyte production index

132

1123

1.18

1.06

2.3

2.0

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

489

1.27

1.04

1.2

1.10

1.06

ratio

1.43

171

(3021879) Hepatitis B virus core Ab [Presence] in Serum

678

6338

1.07

1.04

1.5

1.4

—

(21494890) Protein electrophoresis panel - 24 hour Urine

796

1.21

1.03

1.7

2.0

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.27

1.03

1.4

1.2

—

(3017950) Salicylates [Moles/volume] in Serum or Plasma

2.27

1.03

1.2

1.7

—

2258.40

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

417

0.72

1.03

2.0

2.1

133.29

178.96

ug/min

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.73

1.02

1.1

1.3

—

(3007461) Platelets [#/volume] in Blood

9017

90655

0.95

1.01

32.7

20.4

248.08

250.46

e9/l

2.72

8856

88241

(3005322) IgE [Units/volume] in Serum or Plasma

559

5196

1.08

1.00

1.3

144.74

250.24

u/ml

5.50

507

4825

(3023323) Follitropin [Units/volume] in Serum or Plasma

402

3685

1.09

1.00

1.5

1.4

28.47

25.62

iu/l

0.86

324

3082

(3019768) Coxiella burnetii Ab [Presence] in Serum

1.87

1.00

1.1

1.2

—

(40765089) Chromosome analysis panel - Blood by G-banded

317

1.33

0.98

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

610

1.23

0.98

1.1

1.0

283.54

283.83

mg/l

0.01

547

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.84

0.98

1.0

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.17

0.98

1.0

1.2

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

2.17

0.98

1.2

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

240

1.38

0.97

1.6

2.0

12896.05

14877.20

e6/l

0.06

134

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

173

1.45

0.97

1.1

1.2

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

479

4435

1.08

0.96

1.8

1.9

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.96

0.0

1.0

—

(3008536) Aspergillus sp Ab [Presence] in Serum

165

1.45

0.96

2.9

2.5

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

116

1.55

0.96

1.3

1.8

—

(3009542) Hematocrit [Volume Fraction] of Blood

9013

90593

0.95

0.94

32.9

20.5

39.32

40.53

17.31

8396

85007

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

1.69

0.94

2.2

1.7

8.33

3.01

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

1.69

0.94

2.2

1.7

0.65

0.86

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

1.69

0.94

2.2

1.7

0.49

1.57

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

1.69

0.94

2.2

1.7

2.18

1.65

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

1.69

0.94

2.2

1.7

1.10

0.86

mg/l

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

261

2889

0.90

0.94

1.6

1.7

—

(3035509) Tobramycin [Mass/volume] in Serum or Plasma

1.65

0.94

4.1

3.8

1.51

1.36

mg/l

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

101

1.58

0.93

2.3

4.7

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

981

9324

1.06

0.92

4.2

4.4

32.55

32.23

0.38

711

6491

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

1.71

0.92

1.0

1.1

—

(40768795) Lymph node Pathology biopsy report

764

0.81

0.90

1.1

1.2

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

444

4115

1.08

0.89

1.3

1.4

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

163

1434

1.14

0.88

3.3

3.4

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

538

1.23

0.87

1.1

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

494

1.24

0.86

1.7

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.93

0.84

1.2

1.00

1.28

u/field

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

920

0.84

1.1

1.2

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

1.62

0.84

2.2

1.7

0.87

1.03

mg/l

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.59

0.84

1.1

1.2

25.63

20.15

u/l

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

487

1.23

0.83

1.5

1.6

6.35

6.56

u/l

0.05

393

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

1.75

0.83

1.1

1.2

—

(3036071) Salmonella sp Ab [Titer] in Serum

274

1.31

0.83

1.0

1.1

—

(3045142) Bone marrow Pathology biopsy report

104

892

1.17

0.82

1.4

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

1.87

0.81

1.2

1.1

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

726

1.19

0.81

4.1

4.8

264.83

77.14

u/ml

0.78

219

(4212803) Bone marrow aspirate examination

1.64

0.81

1.1

1.0

—

(3038026) Centromere Ab [Units/volume] in Serum

599

1.20

0.80

1.3

1.2

23.44

47.41

u/ml

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

0.79

0.0

1.0

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.67

0.78

1.0

1.1

—

(40768797) Stomach Pathology biopsy report

1111

10648

1.05

0.78

1.2

—

(3015183) Erythrocyte sedimentation rate

407

0.76

0.78

1.2

—

(3009208) Meadow Fescue IgE Ab [Units/volume] in Serum

0.00

0.77

0.0

1.0

—

15.84

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

153

1356

1.13

0.77

1.5

1.6

0.75

0.80

g/l

0.15

116

1038

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

703

1.18

0.77

1.5

1.3

1.58

1.46

nmol/l

0.39

629

(40768446) Kidney Pathology biopsy report

349

1.26

0.76

1.7

—

(3003338) MCHC [Mass/volume]

7086

70153

1.03

0.76

29.0

17.7

334.26

332.79

g/l

32.54

7028

69548

(3002568) Complement factor B [Mass/volume] in Serum or Plasma

0.00

0.76

0.0

1.1

—

0.22

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

153

1359

1.13

0.75

1.1

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

149

1.41

0.75

1.9

1.6

—

(3012516) Albumin [Mass/volume] in Urine

2203

22612

0.97

0.75

3.3

532.19

403.48

mg/l

0.57

1500

14739

(3029634) Reagin Ab [Titer] in Serum by VDRL

138

1220

1.13

0.73

2.2

2.0

2.40

7.17

titre

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

532

1.20

0.73

1.1

1.2

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1099

0.86

0.73

1.3

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

150

1.40

0.73

1.0

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

203

1839

1.11

0.71

1.7

1.8

3.53

4.50

iu/l

0.99

650

(3018851) Theophylline [Moles/volume] in Serum or Plasma

1.62

0.71

1.5

1.6

52.00

43.25

umol/l

0.43

(3017400) Magnesium [Moles/volume] in Urine

1.92

0.70

1.0

2.79

3.26

mmol/l

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

435

1.22

0.70

1.8

1.5

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

121

1066

1.14

0.69

1.1

1.50

g/l

0.07

113

957

(3044941) Cell count panel - Synovial fluid

106

1209

0.87

0.69

1.5

1.4

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

283

1.27

0.69

1.3

1.2

0.31

0.30

g/l

0.18

225

(3009677) Dengue virus Ab [Presence] in Serum

1.85

0.68

1.0

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.67

0.68

1.0

1.9

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.67

0.68

1.0

1.9

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

583

1.18

0.68

1.3

1.2

58.86

73.35

u/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

127

1.42

0.67

1.2

1.0

—

(4281824) Cell count and differential, peritoneal fluid

736

0.84

0.67

1.4

1.2

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

120

0.58

0.67

1.3

3.3

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

438

1.21

0.66

1.9

1.5

—

(3026493) Urate [Moles/volume] in Serum or Plasma

2043

20948

0.97

0.66

2.9

2.7

3586.42

4278.49

umol/l

0.35

1760

18386

(3020356) Listeria sp identified in Specimen by Organism specific culture

1.59

0.65

1.1

1.2

—

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

1.59

0.65

1.1

1.5

22.40

21.85

pmol/l

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

559

1.18

0.64

1.3

1.2

33.43

12.46

u/ml

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

587

1.18

0.64

1.3

1.2

24.50

45.13

u/ml

—

(3002523) Influenza virus A Ag [Presence] in Specimen

122

1370

0.89

0.64

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

798

8326

0.95

0.63

1.6

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

215

2342

0.92

0.63

1.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

490

5175

0.94

0.62

1.2

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

101

0.59

0.62

1.2

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.63

0.62

1.0

1.1

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

470

1.19

0.61

1.4

5.02

4.68

umol/l

0.29

430

(40758358) Immune stain study

1.67

0.61

1.0

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

113

1.42

0.60

1.4

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

191

1.31

0.60

1.0

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

191

1.31

0.60

1.0

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

191

1.31

0.60

1.0

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

191

1.31

0.60

1.0

1.1

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

243

0.74

0.59

1.0

16.71

12.45

u/ml

0.24

140

(3003740) Influenza virus B Ag [Presence] in Specimen

123

1371

0.90

0.58

1.1

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

530

0.83

0.58

1.3

1.2

—

(3014339) Estrone (E1) [Moles/volume] in Serum or Plasma

0.00

0.58

0.0

1.1

—

215.78

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.58

0.0

7.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

473

1.18

0.58

1.1

1.2

121.38

86.93

u/l

0.90

408

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.51

0.58

3.5

4.6

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

365

0.79

0.58

1.2

1.3

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.48

0.57

1.5

1.1

—

(3049717) Cytology report of Urine Cyto stain

318

2976

1.07

0.57

2.2

2.8

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

210

1934

1.09

0.57

1.3

4.14

5.28

u/ml

0.20

188

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

101

895

1.13

0.56

1.0

1.1

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

483

0.83

0.55

1.2

1.3

1.55

1.53

g/l

0.09

483

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

737

1.14

0.55

3.4

3.8

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

151

1372

1.10

0.55

1.1

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

141

1278

1.10

0.54

1.4

1.2

58.93

37.33

u/l

0.62

124

1112

(3007463) Buprenorphine [Presence] in Urine

1.58

0.54

3.0

5.6

—

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

186

1.29

0.54

1.3

1.1

19.96

20.13

mmol/l

0.05

166

(3000330) Specific gravity of Urine by Test strip

422

3995

1.06

0.54

4.1

3.4

—

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

1.47

0.53

1.0

2.5

—

70.78

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

125

1.36

0.53

1.7

1.6

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

203

1875

1.08

0.52

1.3

1.4

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

512

0.84

0.52

1.4

1.5

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

143

1.33

0.52

7.1

7.6

—

(3003129) Base excess in Capillary blood by calculation

205

1.27

0.52

1.8

1.11

0.54

mmol/l

0.41

192

(3001556) Androgen free Index in Serum or Plasma

0.61

0.52

1.2

—

(3022670) pH of Venous cord blood

1.50

0.51

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

1.41

0.51

1.1

10.89

14.55

u/l

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

211

1956

1.08

0.51

1.3

16.99

8.51

u/ml

0.68

299

(3023420) DNA double strand Ab [Units/volume] in Serum

837

1.12

0.50

2.1

1.5

28.83

22.97

iu/ml

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

1105

0.89

0.50

2.0

2.6

4.47

8.15

umol/l

3.63

820

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

188

1.28

0.50

5.8

5.7

70.84

70.41

0.03

147

(3014891) Appearance of Pleural fluid

109

1.38

0.50

1.4

1.2

—

(3036670) Protein [Mass/volume] in Synovial fluid

233

1.24

0.50

1.4

1.2

41.95

39.37

g/l

0.42

127

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

228

2121

1.08

0.50

1.3

47.82

36.81

u/ml

0.31

124

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.46

0.50

1.0

1.1

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

173

1592

1.09

0.50

1.3

1.2

1.51

3.76

u/ml

1.01

117

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

192

2073

0.92

0.50

1.5

1.4

—

(3050794) Legionella sp Ab [Presence] in Serum

1.49

0.49

1.1

—

(3042733) HLA Ab [Presence] in Serum

280

1.21

0.48

4.5

4.7

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

154

0.71

0.47

1.1

2.0

1.85

2.00

ug/l

—

(3047189) Immunofixation for 24 hour Urine

375

0.83

0.46

1.2

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

748

0.88

0.45

3.2

3.0

86.05

58.59

mg/l

0.28

561

(3047007) Chlamydophila sp Ab [Presence] in Serum

110

1210

0.91

0.45

1.3

1.2

—

(3033799) Differential panel - Peritoneal fluid

237

1.22

0.45

2.3

1.9

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

191

1776

1.08

0.44

1.3

1.4

258.28

258.95

u/ml

0.01

121

1078

(3041806) Other cells [#/volume] in Blood by Manual count

319

0.81

0.44

1.8

1.5

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

459

1.15

0.44

1.2

25.98

23.28

u/l

0.10

388

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.37

0.44

5.9

6.5

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

140

0.71

0.43

1.1

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

169

1818

0.93

0.42

1.2

1.3

—

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.43

0.41

1.2

35.46

121.29

ug/l

—

(3027305) Fractional oxyhemoglobin in Arterial cord blood

0.00

0.41

0.0

1.1

—

39.72

—

(3028714) Urate [Moles/time] in 24 hour Urine

0.00

0.41

0.0

1.1

—

(3009471) Fatty acids.nonesterified [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

6.8

—

0.23

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.41

0.0

7.1

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

870

1.10

0.41

1.3

0.39

0.40

g/l

0.09

612

(3027135) IgG subclass 1 [Mass/volume] in Serum

871

1.10

0.40

1.3

6.96

6.67

g/l

0.24

614

(3028192) IgG subclass 2 [Mass/volume] in Serum

871

1.10

0.40

1.3

2.81

2.86

g/l

0.07

616

(4062490) Immunoglobulin typing, IgG

872

1.10

0.40

1.4

1.3

—

(3025577) Chromium [Mass/volume] in Blood

475

0.86

0.39

2.0

3.96

2.28

ug/l

0.40

398

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

453

0.86

0.39

2.0

1.8

—

(3034614) HLA Ag [Interpretation]

0.00

0.39

0.0

1.3

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

305

2898

1.05

0.39

1.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

196

1.22

0.38

1.3

1.2

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

242

1.20

0.38

1.6

2.4

242.17

117.04

ng/l

0.48

164

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

169

1.24

0.38

1.4

1.5

0.31

0.41

ug/l

0.73

101

(3025130) Human papilloma virus identified in Specimen

946

0.91

0.37

1.6

1.7

—

(3021788) Differential panel - Synovial fluid

130

1403

0.93

0.37

1.6

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

178

1666

1.07

0.37

1.5

1.6

104.82

114.02

u/ml

0.59

328

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

195

1831

1.07

0.37

1.5

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

408

0.86

0.37

8.0

5.8

1416.57

8950.44

u/ml

—

(3022411) Androstenedione [Moles/volume] in Serum or Plasma

134

1.27

0.36

1.6

1.9

3.26

4.08

nmol/l

1.03

129

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

395

0.86

0.35

4.9

4.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1329

13010

1.02

0.35

1.7

1.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

245

1.18

0.35

1.1

1.0

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

508

1.12

0.34

1.4

1.3

113.33

336.82

titre

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

255

1.18

0.34

2.4

3.1

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

109

1.28

0.33

1.2

1.1

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

939

9162

1.03

0.32

2.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

212

2234

0.95

0.32

1.1

5.09

7.26

u/ml

0.41

278

(40765096) Chromosome analysis panel by Banding

241

0.83

0.31

1.2

1.1

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

570

0.89

0.31

1.1

10.00

9.31

iu/ml

0.06

130

(3039162) Centromere protein B Ab [Units/volume] in Serum

104

963

1.08

0.31

1.3

64.78

51.52

u/ml

—

(3024471) HLA-A [Type]

286

1.15

0.30

1.0

—

(4146454) Self-monitoring of blood glucose

818

0.92

0.30

2.3

2.7

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

139

1.22

0.28

2.7

3.1

21.16

49.47

mg/l

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

162

0.80

0.28

1.8

1.7

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

103

1.26

0.28

1.0

1.1

0.32

4.10

u/ml

—

(3000475) Leukocytes [#/volume] in Synovial fluid

196

1864

1.05

0.28

1.7

1.6

11815.94

15206.39

e6/l

0.84

141

1329

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

355

1.13

0.27

1.0

1.1

1.60

7.98

u/ml

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

480

0.89

0.27

1.0

—

(3006462) Nitrate [Presence] in Urine

385

1.12

0.26

2.2

3.4

—

(3024932) HLA-DR beta [Type]

281

1.14

0.26

1.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

1.26

0.26

1.0

1.1

0.57

0.73

u/ml

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.70

0.26

1.2

1.1

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

654

1.09

0.26

5.3

3.6

56.11

42.95

u/ml

0.22

646

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

149

0.80

0.25

1.1

1.3

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

362

0.88

0.25

1.2

1.1

—

(3020876) Protein [Mass/time] in 24 hour Urine

896

1.07

0.25

1.8

2.5

1.59

1.44

g/24h

0.19

452

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

276

0.87

0.24

2.0

1.8

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

621

0.92

0.24

1.1

1.2

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.28

0.24

1.2

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

1.28

0.24

1.0

1.1

—

(3006270) Folate [Moles/volume] in Blood

715

1.08

0.24

1.1

1.2

320.04

361.64

nmol/l

1.15

598

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

255

1.14

0.24

5.0

6.2

—

(42528615) Etanercept [Mass/volume] in Serum or Plasma by Immunoassay

1.32

0.23

1.0

1.2

2.06

1.61

mg/l

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

248

2573

0.96

0.23

1.6

71.67

5.78

iu/ml

0.62

571

(40768443) Skin Pathology biopsy report

360

3491

1.03

0.22

1.2

—

(3003531) Amoxicillin IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.21

0.0

1.0

—

(40765955) DNA double strand Ab [Titer] in Pleural fluid by Immunofluorescence

0.00

0.21

0.0

1.1

—

(3046682) IgA [Presence] in Skin by Immunofluorescence

0.00

0.21

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.21

0.0

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

102

0.78

0.21

12.4

7.6

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

105

0.76

0.21

1.0

1.1

—

(3022764) Mononuclear cells/100 leukocytes in Peritoneal fluid

0.00

0.21

0.0

7.9

—

60.60

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.21

0.0

1.7

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

12.62

—

(3015350) Toxocara sp Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

192

1845

1.04

0.20

1.3

1.2

—

(3020093) Fractional oxyhemoglobin in Venous cord blood

0.00

0.20

0.0

1.2

—

71.38

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

654

6667

0.98

0.20

2.2

12.22

12.47

nmol/l

0.31

575

5955

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

117

1230

0.95

0.20

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

1.20

0.19

1.0

1.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

1.15

0.19

1.2

1.5

232.33

331.00

umol/24h

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

607

1.07

0.19

1.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

1032

0.95

0.18

1.7

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

282

2738

1.03

0.18

3.0

3.5

167.07

2547.65

u/ml

1.56

241

2337

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

252

2595

0.97

0.17

1.8

1.7

48.57

40.53

nmol/l

2.84

246

2518

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

201

1942

1.04

0.17

2.4

2.3

177.29

112.53

ug/min

1.09

112

1188

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

309

3007

1.03

0.17

2.1

1.8

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

0.75

0.17

1.0

0.49

2.54

u/ml

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

1.18

0.16

4.4

4.8

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

1.16

0.16

4.4

5.0

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

139

1.15

0.16

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

266

0.90

0.15

1.9

1.7

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

5376

53936

0.99

0.15

3.2

3.1

—

(3000285) Sodium [Moles/volume] in Blood

111

1.17

0.15

1.2

1.1

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.18

0.14

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

752

1.05

0.14

1.2

1.4

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

919

0.96

0.13

1.9

1.6

55.59

59.11

0.42

590

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

177

1822

0.97

0.13

2.0

1.9

195.01

201.31

pmol/l

0.35

166

1724

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

100

0.80

0.13

1.1

1.2

—

(3048879) Bone marrow aspiration report

211

0.90

0.13

2.0

1.9

—

(3044007) Cell count panel - Peritoneal fluid

219

1.10

0.12

1.5

1.9

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

171

1.11

0.12

5.5

6.1

—

(3035933) Granulocytes/100 leukocytes in Blood

313

0.93

0.12

1.7

1.3

—

(3029396) Erythrocyte agglutination [Presence] in Blood

210

1.09

0.12

3.1

2.9

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

162

1.11

0.11

1.4

2.1

5.95

7.99

mmol/l

2.94

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

267

2717

0.98

0.10

1.4

1.3

—

(3004775) Volume in Urine collected for unspecified duration

626

0.96

0.10

2.2

2.3

677.72

642.92

0.24

419

(3003327) Ova and parasites identified in Stool by Light microscopy

280

2753

1.02

0.09

1.6

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

563

0.96

0.09

1.1

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

134

0.89

0.08

6.2

6.8

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

449

1.05

0.08

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

136

1.10

0.08

1.5

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.83

0.08

1.2

1.1

0.01

3.40

u/ml

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

328

0.94

0.08

1.0

1.1

—

(3027901) Hemoglobin [Mass/volume] in Arterial cord blood

1.09

0.08

1.0

162.57

163.91

g/l

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

391

1.05

0.08

1.0

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

588

1.04

0.08

1.3

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

588

1.04

0.08

1.3

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

133

0.90

0.07

1.1

1.5

5.43

9.70

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

692

0.97

0.07

1.7

1.5

35.26

29.73

0.69

428

(44813793) Dust mix specific IgE antibody measurement

589

1.04

0.07

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

589

1.04

0.07

1.3

1.2

—

(3027035) Albumin [Mass/time] in 24 hour Urine

0.86

0.07

1.3

1.2

—

526.17

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

196

1.07

0.07

2.0

1.9

0.09

0.19

nmol/l

1.52

140

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

442

4460

0.99

0.06

1.0

1.1

—

(3009508) Creatinine [Moles/volume] in Urine

2491

24977

1.00

0.06

3.4

3.3

7.55

7.78

mmol/l

1.47

2125

21204

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

193

0.93

0.06

1.1

—

(40758292) HTLV I+II Ab panel - Serum

138

1.09

0.06

1.5

1.4

—

(3043410) Blood group antigens tested for on Red Blood Cells

223

0.94

0.06

2.1

1.7

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

259

2558

1.01

0.06

1.4

1.3

206.38

225.53

miu/ml

0.34

1166

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

178

1.07

0.05

1.7

1.2

—

(3020650) Glucose [Presence] in Urine

202

0.94

0.05

1.1

1.4

—

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

494

1.03

0.05

1.5

11.10

6.20

u/l

0.56

424

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

593

1.03

0.05

1.3

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

593

1.03

0.05

1.3

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

100

1.10

0.05

1.2

1.1

—

(3048689) Calprotectin [Mass/mass] in Stool

1013

10171

0.99

0.05

2.1

2.5

157.92

132.27

ug/g

0.90

811

8099

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

594

1.03

0.05

1.3

1.2

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

155

1571

0.99

0.05

3.1

3.5

954.71

625.00

u/ml

0.18

141

1444

(3002619) Bacteria identified in Specimen by Culture

169

1.06

0.05

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

554

0.97

0.04

1.3

0.26

3.13

u/ml

5.95

309

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

168

1660

1.01

0.04

2.1

2.0

0.86

0.79

nmol/l

0.67

136

1393

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

356

3538

1.01

0.03

3.1

3.4

121.64

56.57

u/ml

0.36

344

3408

(3038071) Oxygen [Partial pressure] in Mixed venous blood

208

0.96

0.02

6.8

7.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

160

1588

1.01

0.02

1.3

1.2

57.65

39.86

u/ml

0.59

155

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

223

1.03

0.01

1.3

1.6

11.10

8.87

ug/l

0.81

223

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

233

1.03

0.01

6.5

6.9

—

(3016750) Collection duration of Urine

446

0.99

0.00

2.4

2.2

493.76

493.44

min

0.01

331

(3051387) C reactive protein [Mass/volume] in Capillary blood

175

1743

1.00

0.00

5.0

3.4

26.98

27.34

mg/l

0.04

113

1107

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

464

1.01

0.00

6.3

6.6

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

127

1.02

0.00

1.2

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

100

1.00

0.00

1.3

1.5

—

(3006598) pH of Arterial cord blood

147

1.02

0.00

1.0

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.02

0.00

1.0

—

(3024263) Appearance of Synovial fluid

421

1.00

0.00

1.2

1.4

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1014

10132

1.00

0.00

2.1

—

(3014051) Protein [Presence] in Urine by Test strip

211

2112

1.00

0.00

2.4

2.6

—

(40768441) Liver Pathology biopsy report

599

1.00

0.00

1.6

1.4

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

170

1.00

0.00

1.0

1.1

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

198

1.01

0.00

1.5

1.3

29.40

36.90

0.58

130

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

702

1.00

0.00

1.1

—

(3022689) Creatine [Moles/volume] in Urine

233

0.99

0.00

1.7

1.5

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

105

1.05

0.00

14.6

12.5

4.76

5.68

mmol/l

1.36

105

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

0.91

0.00

1.0

23.70

12.87

u/ml

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

0.99

0.00

1.1

—

(3001729) Color of Synovial fluid

0.91

-0.00

1.2

1.5

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.00

-0.00

2.4

5.8

—

(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.0

—

(42868452) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

6.7

—

(3016816) Cytomegalovirus IgG Ab [Presence] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

0.00

-0.00

0.0

1.2

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.02

-0.00

1.4

1.0

—

(3017497) Pine Nut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

0.03

—

(3043614) Bacteria identified in Aspirate by Culture

0.00

-0.00

0.0

1.0

—

(3041198) Albumin [Mass/volume] in Peritoneal dialysis fluid

0.00

-0.00

0.0

9.2

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

4.0

—

(40761593) Coagulation factor VIII Ab [Presence] in Platelet poor plasma by Immunoassay

0.00

-0.00

0.0

1.3

—

(40760087) Plasmodium sp Ab [Presence] in Serum by Immunofluorescence

0.00

-0.00

0.0

1.1

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.95

-0.00

1.7

1.8

—

(3000876) Codfish IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(21494671) JAK2 gene exon 14 targeted mutation analysis in Bone marrow by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3020893) t(14;18)(q32;q21.3)(IGH,BCL2) fusion transcript [Presence] in Blood or Tissue by Molecular genetics method

0.00

-0.00

0.0

1.0

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.91

-0.00

1.6

1.5

—

(3009179) Lactate [Moles/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1.82

—

(3017986) Aspergillus versicolor IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

16.84

—

(3010801) 5-Hydroxyindoleacetate [Moles/volume] in 24 hour Urine

0.00

-0.00

0.0

1.0

—

21.00

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint FE and mortality.

Females

Parameter	HR [95% CI]	p-value
FE	3.467 [3.14, 3.83]	< 0.001
Birth year	0.993 [0.99, 1.0]	0.091

During the follow-up period (1.1.1998 — 31.12.2019), 10372 out of 32811 females with FE died.

Males

Parameter	HR [95% CI]	p-value
FE	3.414 [3.09, 3.78]	< 0.001
Birth year	0.987 [0.98, 1.0]	0.005

During the follow-up period (1.1.1998 — 31.12.2019), 13356 out of 36763 males with FE died.

Mortality risk

Mortality risk for people of age

years, who have FE.

N-year risk	Females	Males
1	0.319%	0.657%
5	2.023%	3.63%
10	4.947%	8.736%
15	8.595%	15.863%
20	15.413%	26.844%

Relationships between endpoints

↥

Index endpoint: FE – Focal epilepsy

GWS hits: 1

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Focal epilepsy

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints